| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.53e-08 | 18 | 199 | 6 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V0A1 MYO7B PSMC3 CHD1 OLA1 ACSL4 MDN1 DNA2 DNAH5 DYNC1H1 DNAH3 IPO8 DNAH2 SAE1 RNF213 CHD8 MSH3 DNAH1 MSH6 DNAH17 CCT8 MACF1 | 2.30e-07 | 614 | 199 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.85e-07 | 28 | 199 | 6 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.63e-06 | 37 | 199 | 6 | GO:0045505 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DAB2IP RGPD4 GBF1 SIRPG RIN2 NGEF ELMOD1 ARHGAP21 IPO5 IPO7 KALRN RAPGEF4 LLGL2 KNDC1 SOS2 NCKAP1L | 5.15e-05 | 507 | 199 | 16 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DAB2IP RGPD4 GBF1 SIRPG RIN2 NGEF ELMOD1 ARHGAP21 IPO5 IPO7 KALRN RAPGEF4 LLGL2 KNDC1 SOS2 NCKAP1L | 5.15e-05 | 507 | 199 | 16 | GO:0030695 |
| GeneOntologyMolecularFunction | microtubule motor activity | 7.01e-05 | 70 | 199 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 9.88e-05 | 2 | 199 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 9.88e-05 | 2 | 199 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | fatty acyl-CoA hydrolase activity | 1.40e-04 | 27 | 199 | 4 | GO:0047617 | |
| GeneOntologyMolecularFunction | acyl-CoA hydrolase activity | 1.62e-04 | 28 | 199 | 4 | GO:0016289 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.82e-04 | 118 | 199 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 2.77e-04 | 32 | 199 | 4 | GO:0140142 | |
| GeneOntologyMolecularFunction | single guanine insertion binding | 2.95e-04 | 3 | 199 | 2 | GO:0032142 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | DAB2IP RGPD4 GBF1 PPP2R2D PPP1R14A ADGRV1 BIRC6 SIRPG SERPINB8 SERPINI2 RIN2 NGEF ELMOD1 ARHGAP21 NSMAF IPO5 IPO7 KALRN RAPGEF4 SAE1 PPP2R2B PPP2R2C PPP2R5C LLGL2 CCNB3 KNDC1 SOS2 NCKAP1L | 4.02e-04 | 1418 | 199 | 28 | GO:0030234 |
| GeneOntologyMolecularFunction | actin filament binding | 4.70e-04 | 227 | 199 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | PSMC3 CHD1 OLA1 MDN1 DNA2 DNAH5 DYNC1H1 DNAH3 DNAH2 RNF213 CHD8 CCT8 MACF1 | 5.02e-04 | 441 | 199 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | guanine/thymine mispair binding | 5.85e-04 | 4 | 199 | 2 | GO:0032137 | |
| GeneOntologyMolecularFunction | single base insertion or deletion binding | 5.85e-04 | 4 | 199 | 2 | GO:0032138 | |
| GeneOntologyMolecularFunction | long-chain fatty acyl-CoA hydrolase activity | 5.98e-04 | 17 | 199 | 3 | GO:0052816 | |
| GeneOntologyMolecularFunction | cadherin binding | DAB2IP SLK UNC45A OLA1 JUP COBLL1 EIF4G2 CCT8 MACF1 TNKS1BP1 CDH18 | 6.20e-04 | 339 | 199 | 11 | GO:0045296 |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 8.84e-04 | 199 | 199 | 8 | GO:1901981 | |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 9.81e-04 | 20 | 199 | 3 | GO:0061608 | |
| GeneOntologyMolecularFunction | GTPase binding | RGPD4 EPRS1 RIN2 IPO5 IPO8 IPO7 TNPO2 RAPGEF4 CSE1L APPL2 NUTF2 | 1.01e-03 | 360 | 199 | 11 | GO:0051020 |
| GeneOntologyMolecularFunction | actin binding | MAP1A TRPM7 MYO7B ACTN4 JMY VILL COBLL1 PKNOX2 LRPPRC PHPT1 XIRP2 FHOD1 MACF1 | 1.07e-03 | 479 | 199 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | thiolester hydrolase activity | 1.22e-03 | 47 | 199 | 4 | GO:0016790 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | DAB2IP GBF1 ARFIP1 VILL CLVS2 SNX31 ATG2B APPL2 GOLPH3L PARD3 | 1.31e-03 | 316 | 199 | 10 | GO:0035091 |
| GeneOntologyMolecularFunction | DNA insertion or deletion binding | 1.44e-03 | 6 | 199 | 2 | GO:0032135 | |
| GeneOntologyMolecularFunction | small GTPase binding | 1.48e-03 | 321 | 199 | 10 | GO:0031267 | |
| GeneOntologyMolecularFunction | ligase activity | 1.84e-03 | 174 | 199 | 7 | GO:0016874 | |
| GeneOntologyMolecularFunction | clathrin light chain binding | 2.01e-03 | 7 | 199 | 2 | GO:0032051 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | RGPD4 USP9X JUP IPO5 IPO8 IPO7 TNPO2 SAE1 AP3B1 PPP2R2B CSE1L APPL2 GOLPH3L CCT8 MACF1 NUTF2 | 4.50e-05 | 515 | 200 | 16 | GO:0072594 |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 4.60e-05 | 41 | 200 | 5 | GO:0070286 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 GBF1 CLTCL1 MAP1A TRARG1 USP9X TTC21A ACTN4 ARFIP1 NUP205 JUP PTPN14 MDN1 STXBP3 CLTC USP7 SNX31 ARHGAP21 DYNC1H1 IPO5 IPO8 IPO7 TNPO2 CITED1 AP3B1 LRPPRC UBE2O CSE1L APPL2 FHOD1 NUTF2 | 4.82e-05 | 1496 | 200 | 31 | GO:0046907 |
| GeneOntologyBiologicalProcess | positive regulation of pinocytosis | 4.85e-05 | 8 | 200 | 3 | GO:0048549 | |
| GeneOntologyBiologicalProcess | negative regulation of hippo signaling | 5.47e-05 | 22 | 200 | 4 | GO:0035331 | |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 NUP205 JUP PTPN14 MDN1 IPO5 IPO8 IPO7 TNPO2 CITED1 CSE1L APPL2 NUTF2 | 8.66e-05 | 378 | 200 | 13 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 NUP205 JUP PTPN14 MDN1 IPO5 IPO8 IPO7 TNPO2 CITED1 CSE1L APPL2 NUTF2 | 8.66e-05 | 378 | 200 | 13 | GO:0006913 |
| GeneOntologyBiologicalProcess | axoneme assembly | 9.38e-05 | 109 | 200 | 7 | GO:0035082 | |
| GeneOntologyBiologicalProcess | microtubule-based process | SPAG1 SLK MAP1A TTC21A PHLDB1 CLTC CC2D2A CEP126 DNAH5 ARHGAP21 DYNC1H1 DNAH3 DNAH2 APOB MEI1 AP3B1 MAP10 DNAH1 LRPPRC LLGL2 DNAH17 MACF1 PARD3 CFAP46 | 9.68e-05 | 1058 | 200 | 24 | GO:0007017 |
| GeneOntologyBiologicalProcess | dendrite development | DAB2IP DLG5 MAP1A LRP8 ACSL4 DIP2A ZNF296 NGEF KALRN RAPGEF4 EIF4G2 KNDC1 | 1.11e-04 | 335 | 200 | 12 | GO:0016358 |
| GeneOntologyBiologicalProcess | intracellular protein transport | RGPD4 CLTCL1 MAP1A TRARG1 USP9X ARFIP1 JUP PTPN14 STXBP3 CLTC SNX31 IPO5 IPO8 IPO7 TNPO2 AP3B1 CSE1L APPL2 NUTF2 | 1.13e-04 | 740 | 200 | 19 | GO:0006886 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 1.25e-04 | 195 | 200 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 GBF1 MAP1A MARK3 USP9X TTC21A JUP CC2D2A IPO5 POLR1A IPO8 IPO7 KALRN TNPO2 RAPGEF4 SAE1 AP3B1 PPP2R2B CSE1L APPL2 GOLPH3L CCT8 MACF1 NUTF2 | 1.54e-04 | 1091 | 200 | 24 | GO:0033365 |
| GeneOntologyBiologicalProcess | import into nucleus | 1.57e-04 | 201 | 200 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | RGPD4 MARK3 JUP IPO5 POLR1A IPO8 IPO7 TNPO2 CSE1L APPL2 CCT8 NUTF2 | 2.27e-04 | 362 | 200 | 12 | GO:0034504 |
| GeneOntologyCellularComponent | axonemal dynein complex | 3.91e-06 | 25 | 205 | 5 | GO:0005858 | |
| GeneOntologyCellularComponent | dynein complex | 1.44e-05 | 54 | 205 | 6 | GO:0030286 | |
| GeneOntologyCellularComponent | protein phosphatase type 2A complex | 2.47e-05 | 18 | 205 | 4 | GO:0000159 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.06e-04 | 10 | 205 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.95e-04 | 161 | 205 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | I band | 2.40e-04 | 166 | 205 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | myofibril | 3.80e-04 | 273 | 205 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.09e-04 | 290 | 205 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | Z disc | 7.39e-04 | 151 | 205 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | sarcomere | 8.16e-04 | 249 | 205 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | cone cell pedicle | 9.39e-04 | 5 | 205 | 2 | GO:0044316 | |
| MousePheno | embryonic lethality prior to organogenesis | RGPD4 EPRS1 MTG1 AARS1 ATP6V0A1 TRPM7 PSMC3 CHD1 NDRG3 NUP205 GMPS PTPN14 STXBP3 UBTF USP7 PKNOX1 AK2 LSM4 ARHGAP21 DYNC1H1 MOB4 POLR1A IPO7 CHD8 DNAJC2 HINFP LIFR USP5 LRPPRC CSE1L GTF3C1 EIF4G2 CCT8 MACF1 | 1.51e-06 | 1204 | 166 | 34 | MP:0013292 |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | RGPD4 AARS1 ATP6V0A1 TRPM7 PSMC3 NDRG3 NUP205 STXBP3 UBTF USP7 PKNOX1 AK2 LSM4 ARHGAP21 DYNC1H1 MOB4 POLR1A IPO7 DNAJC2 HINFP USP5 LRPPRC CSE1L CCT8 MACF1 | 4.45e-06 | 772 | 166 | 25 | MP:0014259 |
| MousePheno | embryonic lethality prior to tooth bud stage | RGPD4 EPRS1 MTG1 AARS1 ATP6V0A1 TRPM7 PSMC3 CHD1 NDRG3 GFPT1 NUP205 GMPS PTPN14 STXBP3 UBTF USP7 PKNOX1 AK2 LSM4 ARHGAP21 DYNC1H1 MOB4 POLR1A IPO7 UBR4 CHD8 DNAJC2 HINFP LIFR USP5 LRPPRC CSE1L GTF3C1 EIF4G2 CCT8 MACF1 | 4.61e-06 | 1383 | 166 | 36 | MP:0013293 |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | RGPD4 AARS1 ATP6V0A1 TRPM7 PSMC3 NDRG3 NUP205 STXBP3 UBTF USP7 PKNOX1 AK2 LSM4 ARHGAP21 DYNC1H1 MOB4 POLR1A IPO7 DNAJC2 HINFP USP5 LRPPRC CSE1L CCT8 MACF1 | 5.22e-06 | 779 | 166 | 25 | MP:0014257 |
| MousePheno | increased circulating potassium level | 1.37e-05 | 121 | 166 | 9 | MP:0005627 | |
| MousePheno | abnormal circulating potassium level | ATP6V0A1 CYP11B1 CYP11B2 GATM RYR1 ABHD8 CUL4A ADCK2 LEFTY1 PPP2R2B | 3.71e-05 | 171 | 166 | 10 | MP:0002668 |
| MousePheno | abnormal potassium level | ATP6V0A1 CYP11B1 CYP11B2 GATM RYR1 ABHD8 CUL4A ADCK2 LEFTY1 PPP2R2B | 1.17e-04 | 196 | 166 | 10 | MP:0020887 |
| MousePheno | abnormal potassium ion homeostasis | ATP6V0A1 CYP11B1 CYP11B2 GATM RYR1 ABHD8 CUL4A ADCK2 LEFTY1 PPP2R2B | 1.27e-04 | 198 | 166 | 10 | MP:0011978 |
| MousePheno | abnormal urine progesterone level | 1.40e-04 | 2 | 166 | 2 | MP:0011545 | |
| MousePheno | abnormal urine deoxycorticosterone level | 1.40e-04 | 2 | 166 | 2 | MP:0011552 | |
| MousePheno | decreased urine corticosterone level | 1.40e-04 | 2 | 166 | 2 | MP:0011550 | |
| MousePheno | increased urine deoxycorticosterone level | 1.40e-04 | 2 | 166 | 2 | MP:0011553 | |
| MousePheno | increased urine progesterone level | 1.40e-04 | 2 | 166 | 2 | MP:0011546 | |
| MousePheno | abnormal sarcoplasmic reticulum morphology | 1.42e-04 | 23 | 166 | 4 | MP:0004088 | |
| MousePheno | uterus cyst | 2.53e-04 | 11 | 166 | 3 | MP:0009082 | |
| Domain | ARM-type_fold | GBF1 CLTCL1 USP9X UNC45A JUP CLTC UTP20 IPO5 IPO8 IPO7 TNPO2 UBR4 APOB FRYL ARMC9 MEI1 AP3B1 PPP2R5C CSE1L FHOD1 EIF4G2 EIF4G3 | 1.52e-11 | 339 | 200 | 22 | IPR016024 |
| Domain | ATPase_dyneun-rel_AAA | 3.91e-09 | 14 | 200 | 6 | IPR011704 | |
| Domain | AAA_5 | 3.91e-09 | 14 | 200 | 6 | PF07728 | |
| Domain | - | USP9X UNC45A JUP UTP20 IPO5 IPO8 IPO7 TNPO2 FRYL ARMC9 AP3B1 PPP2R5C CSE1L FHOD1 | 1.25e-07 | 222 | 200 | 14 | 1.25.10.10 |
| Domain | ARM-like | USP9X UNC45A JUP UTP20 IPO5 IPO8 IPO7 TNPO2 FRYL ARMC9 MEI1 AP3B1 PPP2R5C CSE1L FHOD1 | 2.30e-07 | 270 | 200 | 15 | IPR011989 |
| Domain | Dynein_heavy_chain_D4_dom | 2.48e-07 | 14 | 200 | 5 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.48e-07 | 14 | 200 | 5 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.48e-07 | 14 | 200 | 5 | IPR013602 | |
| Domain | DHC_N2 | 2.48e-07 | 14 | 200 | 5 | PF08393 | |
| Domain | IMPORTIN_B_NT | 2.48e-07 | 14 | 200 | 5 | PS50166 | |
| Domain | MT | 2.48e-07 | 14 | 200 | 5 | PF12777 | |
| Domain | AAA_8 | 2.48e-07 | 14 | 200 | 5 | PF12780 | |
| Domain | DHC_fam | 3.69e-07 | 15 | 200 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 3.69e-07 | 15 | 200 | 5 | PF03028 | |
| Domain | Dynein_heavy_dom | 3.69e-07 | 15 | 200 | 5 | IPR004273 | |
| Domain | Importin-beta_N | 7.46e-07 | 17 | 200 | 5 | IPR001494 | |
| Domain | Cse1 | 1.21e-06 | 3 | 200 | 3 | PF08506 | |
| Domain | Cse1 | 1.21e-06 | 3 | 200 | 3 | IPR013713 | |
| Domain | PP2A_PR55_CS | 4.80e-06 | 4 | 200 | 3 | IPR018067 | |
| Domain | PP2A_PR55 | 4.80e-06 | 4 | 200 | 3 | IPR000009 | |
| Domain | PR55_2 | 4.80e-06 | 4 | 200 | 3 | PS01025 | |
| Domain | PR55_1 | 4.80e-06 | 4 | 200 | 3 | PS01024 | |
| Domain | IBN_N | 1.59e-05 | 15 | 200 | 4 | PF03810 | |
| Domain | - | MTG1 DLG5 MYO7B PSMC3 CHD1 OLA1 MDN1 MPP4 AK2 DNA2 DNAH5 DYNC1H1 DNAH3 DIRAS1 DNAH2 RNF213 CHD8 MSH3 AAGAB DNAH1 MSH6 CARD11 | 1.73e-05 | 746 | 200 | 22 | 3.40.50.300 |
| Domain | IBN_N | 2.10e-05 | 16 | 200 | 4 | SM00913 | |
| Domain | DHC_N1 | 6.51e-05 | 8 | 200 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 6.51e-05 | 8 | 200 | 3 | IPR013594 | |
| Domain | Clathrin_H-chain_propeller_rpt | 1.14e-04 | 2 | 200 | 2 | IPR022365 | |
| Domain | Clathrin-link | 1.14e-04 | 2 | 200 | 2 | PF09268 | |
| Domain | - | 1.14e-04 | 2 | 200 | 2 | 2.130.10.110 | |
| Domain | DNA_mismatch_repair_MutS_N | 1.14e-04 | 2 | 200 | 2 | IPR016151 | |
| Domain | Clathrin_heavy_chain | 1.14e-04 | 2 | 200 | 2 | IPR016341 | |
| Domain | Cyt_P450_mitochondrial | 1.14e-04 | 2 | 200 | 2 | IPR002399 | |
| Domain | Clathrin_H-chain_propeller_N | 1.14e-04 | 2 | 200 | 2 | IPR001473 | |
| Domain | Clathrin_H-chain_link/propller | 1.14e-04 | 2 | 200 | 2 | IPR016025 | |
| Domain | Clathrin_propel | 1.14e-04 | 2 | 200 | 2 | PF01394 | |
| Domain | - | 1.14e-04 | 2 | 200 | 2 | 3.40.1170.10 | |
| Domain | Clathrin_H-chain_linker_core | 1.14e-04 | 2 | 200 | 2 | IPR015348 | |
| Domain | P-loop_NTPase | MTG1 DLG5 MYO7B PSMC3 CHD1 OLA1 MDN1 MPP4 AK2 DNA2 DNAH5 DYNC1H1 DNAH3 DIRAS1 DNAH2 RNF213 CHD8 MSH3 AAGAB DNAH1 MSH6 CARD11 | 1.16e-04 | 848 | 200 | 22 | IPR027417 |
| Domain | TPR-like_helical_dom | RGPD4 SPAG1 CLTCL1 TTC21A UNC45A CDC16 CLTC POLR1A LRPPRC CFAP46 | 2.14e-04 | 233 | 200 | 10 | IPR011990 |
| Domain | Clathrin_H-chain_linker | 3.40e-04 | 3 | 200 | 2 | IPR012331 | |
| Domain | DNA_mismatch_repair_MutS-lik_N | 3.40e-04 | 3 | 200 | 2 | IPR007695 | |
| Domain | MutS_I | 3.40e-04 | 3 | 200 | 2 | PF01624 | |
| Domain | CLH | 3.40e-04 | 3 | 200 | 2 | SM00299 | |
| Domain | HEAT | 3.87e-04 | 58 | 200 | 5 | IPR000357 | |
| Domain | - | 4.03e-04 | 207 | 200 | 9 | 1.25.40.10 | |
| Domain | Ndr | 6.75e-04 | 4 | 200 | 2 | PF03096 | |
| Domain | NDRG | 6.75e-04 | 4 | 200 | 2 | IPR004142 | |
| Domain | DNA_mmatch_repair_MutS_con_dom | 6.75e-04 | 4 | 200 | 2 | IPR007860 | |
| Domain | MutS_II | 6.75e-04 | 4 | 200 | 2 | PF05188 | |
| Domain | AAA | 9.28e-04 | 144 | 200 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 9.28e-04 | 144 | 200 | 7 | IPR003593 | |
| Domain | MUTSd | 1.12e-03 | 5 | 200 | 2 | SM00533 | |
| Domain | MUTSac | 1.12e-03 | 5 | 200 | 2 | SM00534 | |
| Domain | MutS_V | 1.12e-03 | 5 | 200 | 2 | PF00488 | |
| Domain | DNA_mismatch_repair_MutS_clamp | 1.12e-03 | 5 | 200 | 2 | IPR007861 | |
| Domain | DNA_MISMATCH_REPAIR_2 | 1.12e-03 | 5 | 200 | 2 | PS00486 | |
| Domain | MutS_IV | 1.12e-03 | 5 | 200 | 2 | PF05190 | |
| Domain | MutS_III | 1.12e-03 | 5 | 200 | 2 | PF05192 | |
| Domain | DNA_mismatch_repair_MutS_C | 1.12e-03 | 5 | 200 | 2 | IPR000432 | |
| Domain | PKNOX/Meis_N | 1.12e-03 | 5 | 200 | 2 | IPR032453 | |
| Domain | DNA_mismatch_repair_MutS_core | 1.12e-03 | 5 | 200 | 2 | IPR007696 | |
| Domain | Meis_PKNOX_N | 1.12e-03 | 5 | 200 | 2 | PF16493 | |
| Domain | DMAP_binding | 1.12e-03 | 5 | 200 | 2 | PF06464 | |
| Domain | RasGEFN | 1.21e-03 | 20 | 200 | 3 | SM00229 | |
| Domain | RasGEF_N | 1.40e-03 | 21 | 200 | 3 | PF00618 | |
| Domain | CRAL_TRIO | 1.40e-03 | 21 | 200 | 3 | PF00650 | |
| Domain | EPHD | 1.60e-03 | 22 | 200 | 3 | PS51805 | |
| Domain | Ras-like_Gua-exchang_fac_N | 1.60e-03 | 22 | 200 | 3 | IPR000651 | |
| Domain | RASGEF_NTER | 1.60e-03 | 22 | 200 | 3 | PS50212 | |
| Domain | MA3 | 1.66e-03 | 6 | 200 | 2 | SM00544 | |
| Domain | MA3 | 1.66e-03 | 6 | 200 | 2 | PF02847 | |
| Domain | DMAP1-bd | 1.66e-03 | 6 | 200 | 2 | IPR010506 | |
| Domain | Initiation_fac_eIF4g_MI | 1.66e-03 | 6 | 200 | 2 | IPR003891 | |
| Domain | MI | 1.66e-03 | 6 | 200 | 2 | PS51366 | |
| Domain | DMAP_binding | 1.66e-03 | 6 | 200 | 2 | SM01137 | |
| Domain | HEAT | 1.72e-03 | 48 | 200 | 4 | PF02985 | |
| Domain | - | 1.78e-03 | 119 | 200 | 6 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 1.78e-03 | 119 | 200 | 6 | IPR029058 | |
| Domain | - | 1.83e-03 | 23 | 200 | 3 | 3.40.525.10 | |
| Domain | Spectrin | 1.83e-03 | 23 | 200 | 3 | PF00435 | |
| Domain | GUANYLATE_KINASE_2 | 1.83e-03 | 23 | 200 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 1.83e-03 | 23 | 200 | 3 | PS00856 | |
| Domain | TPR_REGION | 2.03e-03 | 165 | 200 | 7 | PS50293 | |
| Domain | TPR | 2.03e-03 | 165 | 200 | 7 | PS50005 | |
| Domain | PH_dom-like | DAB2IP RGPD4 MYO7B PHLDB1 MTMR11 PTPN14 NGEF ARHGAP21 NSMAF KALRN APPL2 SOS2 | 2.21e-03 | 426 | 200 | 12 | IPR011993 |
| Domain | Clathrin | 2.31e-03 | 7 | 200 | 2 | PF00637 | |
| Domain | eIF5C | 2.31e-03 | 7 | 200 | 2 | SM00515 | |
| Domain | 4HBT | 2.31e-03 | 7 | 200 | 2 | PF03061 | |
| Domain | W2 | 2.31e-03 | 7 | 200 | 2 | PF02020 | |
| Domain | Thioestr_dom | 2.31e-03 | 7 | 200 | 2 | IPR006683 | |
| Domain | W2 | 2.31e-03 | 7 | 200 | 2 | PS51363 | |
| Domain | CHCR | 2.31e-03 | 7 | 200 | 2 | PS50236 | |
| Domain | W2_domain | 2.31e-03 | 7 | 200 | 2 | IPR003307 | |
| Domain | SEC14 | 2.34e-03 | 25 | 200 | 3 | SM00516 | |
| Domain | RASGEF | 2.62e-03 | 26 | 200 | 3 | PS00720 | |
| Domain | CRAL_TRIO | 2.93e-03 | 27 | 200 | 3 | PS50191 | |
| Domain | Clathrin_H-chain/VPS_repeat | 3.06e-03 | 8 | 200 | 2 | IPR000547 | |
| Domain | EPL1 | 3.06e-03 | 8 | 200 | 2 | PF10513 | |
| Domain | Enhancer_polycomb-like_N | 3.06e-03 | 8 | 200 | 2 | IPR019542 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 9.69e-06 | 27 | 154 | 5 | M47755 | |
| Pathway | BIOCARTA_IRES_PATHWAY | 4.33e-05 | 7 | 154 | 3 | M22028 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 4.67e-05 | 19 | 154 | 4 | M22005 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 4.67e-05 | 19 | 154 | 4 | M47525 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 8.60e-05 | 22 | 154 | 4 | M47919 | |
| Pathway | KEGG_TIGHT_JUNCTION | 9.92e-05 | 132 | 154 | 8 | M11355 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.00e-04 | 43 | 154 | 5 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.25e-04 | 45 | 154 | 5 | M47670 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 AARS1 ACOT7 PSMC3 CHD1 ACTN4 UNC45A BIRC6 GFPT1 NUP205 GMPS ACSL4 JUP PHLDB1 SAFB PTPN14 MDN1 UBTF CLTC USP7 ANKIB1 UTP20 ACAA2 DYNC1H1 POLR1A IPO7 UBR4 SAE1 CHD8 MSH3 MSH6 USP5 LRPPRC CSE1L GTF3C1 FHOD1 EIF4G2 CCT8 MACF1 EIF3A PARD3 MAP2K3 | 8.28e-19 | 1353 | 206 | 42 | 29467282 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 AARS1 SLK ATP6V0A1 GBF1 USP9X PSMC3 CHD1 ACTN4 UNC45A OLA1 GFPT1 NUP205 JUP SAFB MDN1 STXBP3 UBTF CDC16 CLTC USP7 CC2D2A UTP20 DNAH5 DYNC1H1 NPAS2 IPO5 POLR1A IPO8 IPO7 UBR4 APOB MSH3 AP3B1 MSH6 LRPPRC UBE2O CSE1L GTF3C1 EIF4G2 CCT8 EIF3A GALNT5 | 8.46e-19 | 1425 | 206 | 43 | 30948266 |
| Pubmed | AARS1 USP9X PSMC3 CHD1 ACTN4 BIRC6 GFPT1 NUP205 GMPS MDN1 UBTF CLTC USP7 UTP20 DYNC1H1 IPO5 POLR1A IPO7 UBR4 CHD8 FRYL MSH6 USP5 LRPPRC UBE2O CSE1L GTF3C1 MACF1 TNKS1BP1 EIF4G3 | 4.06e-18 | 653 | 206 | 30 | 22586326 | |
| Pubmed | EPRS1 SLK ATP6V0A1 MAP1A MARK3 USP9X TTC21A ACOT7 PSMC3 ACTN4 OLA1 JMY DIP2A JUP PHLDB1 SAFB CLCN6 CLTC NGEF USP7 LSM4 ARHGAP21 DYNC1H1 MOB4 IPO5 KALRN RAPGEF4 AP3B1 USP5 LRPPRC PPP2R2C UBE2O CSE1L APPL2 PAFAH1B2 EIF4G2 KNDC1 CCT8 MACF1 TNKS1BP1 EIF3A EIF4G3 | 6.22e-18 | 1431 | 206 | 42 | 37142655 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EPRS1 AARS1 SLK GBF1 USP9X ACOT7 PSMC3 ACTN4 UNC45A OLA1 ARFIP1 BIRC6 GFPT1 NUP205 GMPS JUP USP7 ACAA2 DYNC1H1 MOB4 CUL4A IPO5 PRUNE2 CACNA1S IPO7 UBR4 SAE1 FRYL ARMC9 AP3B1 MSH6 USP5 UBE2O PPP2R5C CSE1L APPL2 PAFAH1B2 CCT8 MACF1 TNKS1BP1 EIF3A IKBKB | 1.13e-17 | 1455 | 206 | 42 | 22863883 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPRS1 AARS1 CLTCL1 PPP2R2D ACOT7 PSMC3 ACTN4 OLA1 GFPT1 RYR1 SAFB MDN1 STXBP3 CLTC USP7 AK2 DYNC1H1 IPO5 UBR4 CHD8 AP3B1 DNAH1 MSH6 USP5 LRPPRC LLGL2 CSE1L GOLPH3L CCT8 MACF1 EIF3A NUTF2 | 2.00e-17 | 807 | 206 | 32 | 30575818 |
| Pubmed | EPRS1 DLG5 USP9X PSMC3 ACTN4 LRCH1 GMPS JUP PTPN14 MDN1 CLTC USP7 DYNC1H1 MOB4 CUL4A IPO5 UBR4 MSH6 CSE1L GTF3C1 EIF4G2 CCT8 TNKS1BP1 | 3.30e-16 | 399 | 206 | 23 | 37536630 | |
| Pubmed | EPRS1 AARS1 MAP1A USP9X ACOT7 PSMC3 UNC45A BIRC6 GFPT1 NUP205 ACSL4 STXBP3 GLDC DYNC1H1 POLR1A UBR4 SAE1 CHD8 MSH6 USP5 LRPPRC GTF3C1 EIF4G2 EIF3A | 1.81e-14 | 534 | 206 | 24 | 35032548 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPRS1 AARS1 SLK GBF1 USP9X ACOT7 PSMC3 ACTN4 UNC45A GMPS MDN1 CLTC USP7 AK2 DYNC1H1 IPO5 IPO7 TNPO2 UBR4 SAE1 AP3B1 MSH6 USP5 LRPPRC UBE2O CSE1L GTF3C1 PPT1 CCT8 MACF1 EIF3A NUTF2 EIF4G3 | 6.25e-14 | 1149 | 206 | 33 | 35446349 |
| Pubmed | AARS1 CHD1 UNC45A OLA1 GFPT1 NUP205 GMPS SAFB MDN1 UBTF CDC16 USP7 CUL4A IPO5 POLR1A IPO7 UBR4 SAE1 RNF213 CHD8 MSH3 MSH6 USP5 CSE1L PHPT1 GTF3C1 EIF4G2 CCT8 EIF3A NUTF2 MAP2K3 | 7.62e-14 | 1014 | 206 | 31 | 32416067 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPRS1 AARS1 SLK USP9X PSMC3 CHD1 ACTN4 UNC45A OLA1 BIRC6 GFPT1 GMPS JUP CLTC USP7 SCO1 AK2 LSM4 DYNC1H1 CUL4A IPO5 IPO7 UBR4 AP3B1 DNAJC2 MSH6 USP5 LRPPRC UBE2O CSE1L FHOD1 EIF4G2 CCT8 MACF1 TNKS1BP1 EIF3A | 1.46e-13 | 1415 | 206 | 36 | 28515276 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPRS1 AARS1 USP9X PSMC3 SAFB MDN1 CLTC USP7 DYNC1H1 UBR4 SAE1 RNF213 CHD8 MSH3 MSH6 USP5 CSE1L GTF3C1 EIF4G2 | 1.58e-13 | 332 | 206 | 19 | 32786267 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | AARS1 USP9X ACTN4 BIRC6 GMPS MDN1 CLTC USP7 DYNC1H1 IPO5 IPO7 UBR4 USP5 CSE1L PAFAH1B2 EIF4G2 CCT8 EIF3A NCKAP1L | 2.98e-13 | 344 | 206 | 19 | 30333137 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPRS1 TTC21A SYNC BIRC6 GFPT1 RYR1 NUP205 GMPS TMCO4 KMT2C DIP2A JUP MDN1 CLTC UTP20 SNX31 DYNC1H1 DNAH3 TNPO2 UBR4 DNAH2 RNF213 MSH6 GTF3C1 CCT8 EIF3A | 3.64e-13 | 736 | 206 | 26 | 29676528 |
| Pubmed | EPRS1 GBF1 USP9X PSMC3 ACTN4 UNC45A NUP205 GMPS MDN1 CLTC USP7 DYNC1H1 IPO5 IPO8 IPO7 UBR4 AP3B1 USP5 LRPPRC UBE2O CSE1L EIF4G2 CCT8 EIF3A | 8.32e-13 | 638 | 206 | 24 | 33239621 | |
| Pubmed | EPRS1 DLG5 MARK3 USP9X UNC45A ARFIP1 GFPT1 GMPS JUP FAM135A ARHGAP21 DYNC1H1 IPO5 IPO7 COBLL1 ATG2B AP3B1 LRPPRC CSE1L EIF4G2 CCT8 MACF1 TNKS1BP1 EIF4G3 PARD3 | 1.08e-12 | 708 | 206 | 25 | 39231216 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | USP9X GATM OLA1 GFPT1 GMPS JUP STXBP3 LSM4 ARHGAP21 IPO5 IPO7 TNPO2 UBR4 AP3B1 MSH6 PPP2R2B PPP2R5C APPL2 MACF1 TNKS1BP1 EIF4G3 | 2.86e-12 | 498 | 206 | 21 | 36634849 |
| Pubmed | EPRS1 AARS1 GBF1 CLTCL1 USP9X PSMC3 OLA1 BIRC6 LRP8 NUP205 ACSL4 MDN1 INTS2 CLTC DYNC1H1 IPO5 IPO7 UBR4 RNF213 MSH3 AP3B1 LRPPRC CSE1L GTF3C1 PPT1 FHOD1 EIF4G2 ADGRE5 EIF3A MAP2K3 NCKAP1L | 3.00e-12 | 1168 | 206 | 31 | 19946888 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | AARS1 GBF1 PPP2R2D ACOT7 PSMC3 CHD1 ACTN4 UNC45A GFPT1 NUP205 GMPS PTPN14 SCO1 IPO5 IPO8 IPO7 UBR4 SAE1 AP3B1 MSH6 USP5 LRPPRC UBE2O CSE1L PHPT1 GTF3C1 CCT8 EIF3A | 5.88e-12 | 974 | 206 | 28 | 28675297 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RGPD4 EPRS1 AARS1 CLTCL1 PPP2R2D PSMC3 ACTN4 UNC45A GFPT1 ACSL4 MDN1 UBTF CLTC DYNC1H1 IPO8 IPO7 UBR4 SAE1 LRPPRC PPP2R2B CCT8 TNKS1BP1 EIF3A | 8.05e-12 | 647 | 206 | 23 | 26618866 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZNF131 EPRS1 AARS1 SLK MAP1A ACOT7 CHD1 UNC45A ARFIP1 GFPT1 GMPS JUP SAFB UBTF USP7 AK2 ARHGAP21 ATG2B MSH6 UBE2O FHOD1 EIF4G2 CCT8 MACF1 TNKS1BP1 EIF3A EIF4G3 | 1.28e-11 | 934 | 206 | 27 | 33916271 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KBTBD3 ZNF444 MARK3 TTC21A ADGRV1 LRP8 GMPS TMCO4 KMT2C PHLDB1 INTS2 RIN2 NGEF ANKIB1 NSMAF NPAS2 CUL4A PRUNE2 POLR1A RNF213 FRYL DNAH1 PKNOX2 LRPPRC PPP2R2C GTF3C1 KNDC1 DIP2C TJAP1 MACF1 EIF4G3 PARD3 MAP2K3 SOS2 | 1.46e-11 | 1489 | 206 | 34 | 28611215 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | CLTCL1 PPP2R2D PSMC3 ACTN4 NUP205 INTS2 SCO1 DYNC1H1 MOB4 IPO8 IPO7 UBR4 LRPPRC PPP2R2B PPP2R2C PPP2R5C CSE1L PHPT1 CCT8 EIF3A PARD3 | 3.92e-11 | 573 | 206 | 21 | 28330616 |
| Pubmed | CCDC125 AARS1 PUS3 TRPM7 MARK3 USP9X CHD1 OLA1 BIRC6 GFPT1 NUP205 GMPS KMT2C SAFB INTS2 UBTF CLVS2 CDC16 CLTC USP7 BRD1 GGPS1 IPO5 UBR4 ADCK2 CHD8 MSH6 PPP2R5C LLGL2 LRRC20 PAFAH1B2 | 7.40e-11 | 1327 | 206 | 31 | 32694731 | |
| Pubmed | 1.16e-10 | 14 | 206 | 6 | 9373155 | ||
| Pubmed | EPRS1 SLK USP9X UNC45A KMT2C JUP PTPN14 CDC16 CLTC USP7 DYNC1H1 ATG2B CHD8 AP3B1 MSH6 UBE2O GTF3C1 CCT8 TNKS1BP1 PARD3 | 1.30e-10 | 549 | 206 | 20 | 38280479 | |
| Pubmed | AARS1 USP9X PSMC3 NUP205 MDN1 CLTC USP7 DYNC1H1 IPO5 LRPPRC CSE1L CCT8 EIF3A | 2.10e-10 | 197 | 206 | 13 | 31620119 | |
| Pubmed | EPRS1 AARS1 GBF1 PSMC3 OLA1 GFPT1 NUP205 ACSL4 KMT2C JUP CLTC USP7 LSM4 DYNC1H1 IPO5 UBR4 LRPPRC UBE2O CSE1L CCT8 MACF1 EIF3A | 3.27e-10 | 711 | 206 | 22 | 33022573 | |
| Pubmed | EPRS1 DLG5 MARK3 ACOT7 PSMC3 ACTN4 UNC45A OLA1 GFPT1 GMPS JUP PTPN14 CLTC USP7 DYNC1H1 CUL4A IPO5 IPO7 SAE1 AP3B1 DNAH1 LRPPRC CSE1L PPT1 EIF4G2 CCT8 TNKS1BP1 PARD3 MAP2K3 | 3.60e-10 | 1247 | 206 | 29 | 27684187 | |
| Pubmed | EPRS1 AARS1 ATP6V0A1 TRPM7 USP9X GATM ACTN4 SYNC GFPT1 DIP2A CLTC NGEF USP7 PKNOX1 ARHGAP21 DYNC1H1 IPO5 KALRN TNPO2 UBR4 RAPGEF4 MSH3 UBE2O APPL2 PPT1 EIF4G2 MACF1 EIF4G3 SOS2 | 7.16e-10 | 1285 | 206 | 29 | 35914814 | |
| Pubmed | DAB2IP RGPD4 EPRS1 MAP1A USP9X ACTN4 NDRG3 BIRC6 GMPS SAFB CDC16 CLTC USP7 DIRAS1 KALRN UBR4 ATG2B LRPPRC UBE2O PPP2R5C CSE1L PHPT1 EIF4G2 KNDC1 CCT8 MACF1 EIF4G3 | 1.03e-09 | 1139 | 206 | 27 | 36417873 | |
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | USP9X BIRC6 GFPT1 SAFB CLTC GGPS1 DYNC1H1 CUL4A IPO7 MSH6 CSE1L EIF4G2 CCT8 EIF3A | 1.04e-09 | 271 | 206 | 14 | 25737280 |
| Pubmed | DAB2IP GBF1 ADGRV1 LRCH1 BIRC6 KMT2C PHLDB1 CLCN6 PRUNE2 CHD8 DIP2C MACF1 TNKS1BP1 | 1.07e-09 | 225 | 206 | 13 | 12168954 | |
| Pubmed | ZNF131 DLG5 ATP6V0A1 TRPM7 MARK3 CHD1 UNC45A ARFIP1 DIP2A JUP PTPN14 MDN1 STXBP3 UBTF CLTC SCO1 LSM4 DNA2 FAM135A IPO8 IPO7 UBR4 AP3B1 DNAJC2 LIFR LRPPRC UBE2O EIF4G2 MACF1 EIF4G3 PARD3 | 1.17e-09 | 1487 | 206 | 31 | 33957083 | |
| Pubmed | PSMC3 ACTN4 BIRC6 RYR1 CLTC ACAA2 ARHGAP21 IPO5 IPO7 KALRN LRPPRC APPL2 XIRP2 ITGB1BP2 EIF4G2 MACF1 EIF3A PARD3 | 1.25e-09 | 497 | 206 | 18 | 23414517 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EPRS1 SLK CLTCL1 USP9X PSMC3 ACTN4 MDN1 CLTC SCO1 DYNC1H1 DNAH3 POLR1A DNAH2 SAE1 AP3B1 MSH6 USP5 GOLPH3L CCT8 MACF1 EIF3A EIF4G3 MAP2K3 | 1.56e-09 | 847 | 206 | 23 | 35235311 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | MAP1A ACOT7 PSMC3 BIRC6 GFPT1 MAP3K4 NUP205 CLTC UTP20 ACAA2 DNAH5 DYNC1H1 POLR1A UBR4 SAE1 MSH3 AP3B1 MSH6 GTF3C1 CCT8 EIF4G3 | 1.62e-09 | 704 | 206 | 21 | 29955894 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 EPRS1 GBF1 USP9X PSMC3 UNC45A BIRC6 GFPT1 NUP205 GMPS MDN1 STXBP3 CLTC USP7 LSM4 DNA2 DYNC1H1 IPO5 POLR1A IPO7 UBR4 SAE1 MSH6 LRPPRC CSE1L GTF3C1 PPT1 CCT8 | 1.93e-09 | 1257 | 206 | 28 | 37317656 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | PSMC3 UNC45A OLA1 ARFIP1 GMPS MDN1 CDC16 DYNC1H1 IPO5 IPO7 CHD8 AP3B1 MSH6 CSE1L FHOD1 CCT8 MACF1 TNKS1BP1 MAP2K3 | 2.35e-09 | 582 | 206 | 19 | 20467437 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPRS1 DLG5 MARK3 ACTN4 UNC45A GFPT1 JUP SAFB UBTF CLTC USP7 UTP20 DYNC1H1 CUL4A IPO5 POLR1A IPO7 APOB LRPPRC LLGL2 CSE1L CCT8 EIF3A MAP2K3 | 2.70e-09 | 949 | 206 | 24 | 36574265 |
| Pubmed | Ubiquitin-Activated Interaction Traps (UBAITs) identify E3 ligase binding partners. | 3.40e-09 | 62 | 206 | 8 | 26508657 | |
| Pubmed | EPRS1 AARS1 CHD1 UNC45A GFPT1 JUP UBTF CLTC DYNC1H1 POLR1A IPO7 UBR4 SAE1 RNF213 MSH6 LRPPRC GTF3C1 MACF1 TNKS1BP1 | 3.96e-09 | 601 | 206 | 19 | 33658012 | |
| Pubmed | GBF1 GFPT1 GLDC CUL4A KALRN UBR4 RNF213 AP3B1 LRPPRC KNDC1 TNKS1BP1 EIF3A IKBKB MAP2K3 | 4.54e-09 | 304 | 206 | 14 | 32235678 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | AARS1 USP9X ACOT7 PSMC3 ACTN4 OLA1 GFPT1 NUP205 GMPS JUP STXBP3 USP7 IPO5 IPO7 LRPPRC CSE1L PAFAH1B2 EIF4G2 EIF3A | 4.65e-09 | 607 | 206 | 19 | 39147351 |
| Pubmed | DAB2IP MARK3 ARFIP1 LRCH1 LRP8 JUP PHLDB1 PTPN14 STXBP3 FAM135A ARHGAP21 LRPPRC LLGL2 APPL2 MACF1 PARD3 | 5.45e-09 | 421 | 206 | 16 | 36976175 | |
| Pubmed | EPRS1 AARS1 ACTN4 UNC45A GFPT1 NUP205 ACSL4 JUP CLTC DYNC1H1 LRPPRC CCT8 TNKS1BP1 EIF3A | 6.32e-09 | 312 | 206 | 14 | 37120454 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | GBF1 ZBTB48 MAP1A CLTC USP7 FHIP1A DYNC1H1 PRUNE2 CACNA1S IPO7 UBR4 NBPF20 PKNOX2 XIRP2 EIF4G3 SOS2 | 7.35e-09 | 430 | 206 | 16 | 35044719 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | SLK PPP2R2D MARK3 PSMC3 UNC45A NUP205 GMPS JUP SAFB GLDC USP7 LSM4 MOB4 CUL4A IPO5 POLR1A IPO7 USP5 LRPPRC UBE2O CSE1L EIF4G2 EIF3A EIF4G3 | 8.16e-09 | 1005 | 206 | 24 | 19615732 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPRS1 DLG5 MARK3 ACTN4 UNC45A LRCH1 GFPT1 NUP205 JUP SAFB PTPN14 UBTF CDC16 CLTC USP7 UTP20 DYNC1H1 IPO7 DNAJC2 MSH6 LRPPRC CSE1L GTF3C1 FHOD1 CCT8 TNKS1BP1 EIF3A | 8.29e-09 | 1257 | 206 | 27 | 36526897 |
| Pubmed | CLTCL1 MARK3 PSMC3 UNC45A JMY NUP205 MDN1 UBTF CLTC USP7 ACAA2 DYNC1H1 IPO5 IPO8 IPO7 TNPO2 UBR4 RNF213 LIFR MSH6 USP5 LRPPRC CSE1L GTF3C1 EIF4G2 CCT8 TNKS1BP1 EIF3A IKBKB | 9.17e-09 | 1440 | 206 | 29 | 30833792 | |
| Pubmed | GBF1 MAP1A UNC45A GFPT1 NUP205 GMPS SAFB CLTC USP7 NSMAF IPO5 ATG2B LRPPRC GTF3C1 XIRP2 EIF3A | 9.22e-09 | 437 | 206 | 16 | 20562859 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.12e-08 | 179 | 206 | 11 | 36261009 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EPRS1 AARS1 ATP6V0A1 USP9X PSMC3 UNC45A GFPT1 NUP205 STXBP3 CLTC UTP20 DYNC1H1 POLR1A IPO7 UBR4 DNAH2 AP3B1 USP5 LRPPRC UBE2O CSE1L EIF4G2 EIF4G3 | 1.14e-08 | 942 | 206 | 23 | 31073040 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DLG5 AARS1 SPAG1 SLK GBF1 USP9X ACOT7 ACTN4 OLA1 GFPT1 NUP205 GMPS ACSL4 JUP SAFB CLTC IPO8 UBR4 RNF213 FRYL MSH6 USP5 LRPPRC UBE2O PAFAH1B2 EIF4G2 CCT8 EIF3A | 1.19e-08 | 1367 | 206 | 28 | 32687490 |
| Pubmed | 1.27e-08 | 104 | 206 | 9 | 36055981 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | EPRS1 GBF1 MARK3 USP9X PSMC3 CHD1 UNC45A OLA1 NUP205 KMT2C JUP CLTC USP7 LSM4 DYNC1H1 MOB4 TNPO2 UBR4 SAE1 FRYL AP3B1 MSH6 LRPPRC EIF4G2 EIF3A EIF4G3 PARD3 | 1.29e-08 | 1284 | 206 | 27 | 17353931 |
| Pubmed | EPRS1 AARS1 GALK2 USP9X ACOT7 UNC45A GMPS ACSL4 JUP CLTC DYNC1H1 IPO5 IPO8 IPO7 SAE1 USP5 LRPPRC PPP2R2C CSE1L GOLPH3L FHOD1 CCT8 | 1.53e-08 | 878 | 206 | 22 | 37223481 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | USP9X ACTN4 UNC45A CLTC ACAA2 DYNC1H1 CUL4A IPO7 UBR4 MACF1 TNKS1BP1 MAP2K3 | 1.90e-08 | 235 | 206 | 12 | 28378594 |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | EPRS1 USP9X PSMC3 NUP205 CLTC USP7 DYNC1H1 IPO7 RNF213 MSH6 LRPPRC UBE2O CSE1L CCT8 | 2.16e-08 | 344 | 206 | 14 | 36282215 |
| Pubmed | EPRS1 PUS3 USP9X PSMC3 CHD1 ACTN4 MDN1 CLTC DYNC1H1 SAE1 LRPPRC UBE2O EIF4G2 CCT8 MACF1 TNKS1BP1 EIF3A | 2.72e-08 | 538 | 206 | 17 | 28524877 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | ACTN4 GMPS JUP SAFB CLTC DYNC1H1 IPO8 IPO7 CHD8 MSH3 USP5 PPP2R2C CSE1L CCT8 | 3.43e-08 | 357 | 206 | 14 | 37059091 |
| Pubmed | 3.53e-08 | 156 | 206 | 10 | 22952844 | ||
| Pubmed | RGPD4 PPP2R2D USP9X ACTN4 GFPT1 GMPS JUP SERPINB8 CLTC DYNC1H1 CUL4A IPO7 UBR4 RNF213 LRPPRC PPP2R2B CSE1L EIF4G2 CCT8 MACF1 TNKS1BP1 | 3.73e-08 | 844 | 206 | 21 | 25963833 | |
| Pubmed | A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis. | 3.86e-08 | 118 | 206 | 9 | 27377895 | |
| Pubmed | 4.13e-08 | 7 | 206 | 4 | 9256245 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | EPRS1 DLG5 SLK UNC45A JUP CLTC DYNC1H1 IPO7 ATG2B EIF4G2 CCT8 TNKS1BP1 | 4.87e-08 | 256 | 206 | 12 | 33397691 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 USP9X CHD1 ACTN4 OLA1 NUP205 JUP PHLDB1 SAFB MDN1 UBTF CLTC UTP20 DYNC1H1 IPO5 POLR1A IPO7 LRPPRC CSE1L GTF3C1 CCT8 MACF1 EIF3A | 5.20e-08 | 1024 | 206 | 23 | 24711643 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DLG5 AARS1 GBF1 TRPM7 MARK3 UNC45A JUP PHLDB1 PTPN14 MDN1 BRD1 ARHGAP21 BICC1 CUL4A COBLL1 FRYL LRPPRC MACF1 TNKS1BP1 EIF4G3 PARD3 | 5.22e-08 | 861 | 206 | 21 | 36931259 |
| Pubmed | EPRS1 AARS1 ACTN4 OLA1 NUP205 GMPS MDN1 STXBP3 CLTC DYNC1H1 IPO5 UBR4 LRPPRC CSE1L PAFAH1B2 EIF4G2 CCT8 MACF1 EIF3A | 5.24e-08 | 707 | 206 | 19 | 19738201 | |
| Pubmed | GBF1 USP9X ACOT7 OLA1 ACSL4 JUP PTPN14 MDN1 RIN2 CLTC USP7 ARHGAP21 IPO5 UBR4 MSH3 MSH6 LRPPRC MACF1 | 5.27e-08 | 634 | 206 | 18 | 34591612 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | AARS1 USP9X MAP3K4 KMT2C DIP2A PHLDB1 MDN1 UBTF USP7 ARHGAP21 POLR1A RAPGEF4 MEI1 GTF3C1 XIRP2 GALNT5 | 5.48e-08 | 497 | 206 | 16 | 36774506 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | DAB2IP DLG5 SPAG1 SLK MARK3 UNC45A OLA1 ARFIP1 NDRG2 JUP ARHGAP21 COBLL1 EIF4G2 CCT8 MACF1 TNKS1BP1 PARD3 | 5.50e-08 | 565 | 206 | 17 | 25468996 |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | PSMC3 PTPN14 DYNC1H1 IPO7 MSH3 MSH6 LRPPRC CSE1L GTF3C1 PPT1 CCT8 | 6.09e-08 | 211 | 206 | 11 | 17314511 |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | NUP205 ACSL4 MDN1 CDC16 UTP20 IPO5 RNF213 USP5 LRPPRC CSE1L EIF4G2 EIF3A | 6.27e-08 | 262 | 206 | 12 | 36880596 |
| Pubmed | DAB2IP RGPD4 SLK USP9X SIRPG MDN1 ZNF394 CLTC NGEF ARHGAP21 DYNC1H1 MOB4 KALRN UBR4 RAPGEF4 CHD8 LRPPRC UBE2O CCT8 TJAP1 MACF1 PARD3 | 7.72e-08 | 963 | 206 | 22 | 28671696 | |
| Pubmed | 7.72e-08 | 216 | 206 | 11 | 31519766 | ||
| Pubmed | 8.04e-08 | 92 | 206 | 8 | 23055941 | ||
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | EPRS1 ACOT7 OLA1 BIRC6 UBTF CLTC DYNC1H1 IPO7 UBR4 PON1 SAE1 CSE1L | 8.36e-08 | 269 | 206 | 12 | 29511261 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | MDN1 USP7 ACAA2 POLR1A TNPO2 CHD8 MSH3 MSH6 LRPPRC CSE1L GTF3C1 | 8.88e-08 | 219 | 206 | 11 | 31353912 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DAB2IP AARS1 SPAG1 PPP2R2D TTC21A PSMC3 ACTN4 OLA1 NUP205 PTPN14 CDC16 SCO1 LSM4 DYNC1H1 MOB4 CUL4A IPO8 COBLL1 ATG2B AP3B1 LRPPRC PPP2R5C CSE1L PAFAH1B2 TNKS1BP1 PARD3 | 9.06e-08 | 1321 | 206 | 26 | 27173435 |
| Pubmed | 1.00e-07 | 20 | 206 | 5 | 21689717 | ||
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | EPRS1 PPP2R2D USP9X PSMC3 GMPS USP7 DYNC1H1 LRPPRC CSE1L CCT8 | 1.04e-07 | 175 | 206 | 10 | 25756610 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | RGPD4 USP9X ACOT7 PSMC3 GFPT1 GMPS ACSL4 DYNC1H1 IPO5 IPO7 UBR4 AP3B1 DNAJC2 LRPPRC CSE1L CCT8 EIF3A EIF4G3 | 1.07e-07 | 665 | 206 | 18 | 30457570 |
| Pubmed | A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export. | EPRS1 AARS1 ATP6V0A1 USP9X PSMC3 GMPS ACSL4 JUP ACAA2 DYNC1H1 POLR1A MSH6 CSE1L EIF4G2 | 1.09e-07 | 392 | 206 | 14 | 33144569 |
| Pubmed | EPRS1 MAP1A PPP2R2D USP9X PSMC3 OLA1 ARFIP1 NUP205 GMPS GLDC CDC16 CLTC USP7 LSM4 CUL4A IPO5 IPO8 IPO7 MSH6 LRPPRC UBE2O CSE1L GTF3C1 EIF4G2 CCT8 EIF3A | 1.11e-07 | 1335 | 206 | 26 | 29229926 | |
| Pubmed | PPP2R2D USP9X BIRC6 KMT2C SAFB TNPO2 UBR4 CHD8 AP3B1 USP5 PPP2R5C CSE1L MACF1 | 1.21e-07 | 335 | 206 | 13 | 15741177 | |
| Pubmed | DAB2IP EPRS1 ACTN4 ARFIP1 KMT2C JUP INTS2 VILL UBTF CLTC DNA2 FAM135A ARHGAP21 BICC1 APOB FRYL AP3B1 PPP2R5C EIF4G2 MACF1 ADGRE5 PARD3 NCKAP1L | 1.43e-07 | 1084 | 206 | 23 | 11544199 | |
| Pubmed | ZBTB48 CHD1 BIRC6 NUP205 KMT2C INTS2 UBTF USP7 DNA2 IPO5 IPO7 CHD8 CSE1L GTF3C1 TNKS1BP1 | 1.57e-07 | 469 | 206 | 15 | 27634302 | |
| Pubmed | 1.59e-07 | 183 | 206 | 10 | 23956138 | ||
| Pubmed | DAB2IP EPRS1 CLTCL1 USP9X ACTN4 JUP CDC16 CLTC AK2 DNAJC2 LRPPRC PPP2R5C GTF3C1 EIF4G3 | 1.93e-07 | 411 | 206 | 14 | 36652389 | |
| Pubmed | EPRS1 AARS1 NUP205 GMPS MDN1 ACAA2 DYNC1H1 MSH6 LRPPRC GTF3C1 CCT8 | 1.97e-07 | 237 | 206 | 11 | 29564676 | |
| Pubmed | Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease. | EPRS1 PPP2R2D USP9X ACTN4 NUP205 GMPS CLTC DYNC1H1 IPO5 IPO8 IPO7 MSH6 LRPPRC CCT8 | 2.37e-07 | 418 | 206 | 14 | 32552912 |
| Pubmed | 2.46e-07 | 72 | 206 | 7 | 36376293 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | AARS1 PSMC3 ACTN4 ADGRV1 GMPS CLTC AK2 CUL4A IPO5 SAE1 RNF213 LRPPRC CSE1L CCT8 EIF3A | 3.12e-07 | 495 | 206 | 15 | 28581483 |
| Pubmed | EPRS1 AARS1 ATP6V0A1 ACOT7 PSMC3 ACTN4 OLA1 GMPS JUP CLTC DYNC1H1 IPO5 DNAH3 SAE1 LRPPRC CSE1L CCT8 EIF3A SOS2 | 3.69e-07 | 803 | 206 | 19 | 36517590 | |
| Pubmed | RGPD4 EPRS1 CLTCL1 NUP205 SAFB CLTC POLR1A LRPPRC EIF3A EIF4G3 | 3.96e-07 | 202 | 206 | 10 | 24639526 | |
| Pubmed | EPRS1 AARS1 MARK3 ACTN4 OLA1 JUP MDN1 CLTC USP7 ARHGAP21 DYNC1H1 MOB4 IPO7 MSH6 LRPPRC CSE1L EIF4G2 CCT8 EIF3A | 4.13e-07 | 809 | 206 | 19 | 32129710 | |
| Pubmed | GBF1 PPP2R2D USP9X PSMC3 UNC45A BIRC6 INTS2 CLTC IPO5 IPO8 IPO7 UBR4 MSH6 LRPPRC CSE1L PPT1 EIF3A | 4.59e-07 | 657 | 206 | 17 | 36180527 | |
| Pubmed | 4.67e-07 | 79 | 206 | 7 | 27325702 | ||
| Pubmed | AARS1 ACTN4 UNC45A OLA1 GFPT1 JUP GLDC AK2 IPO5 IPO7 AP3B1 CSE1L EIF4G2 CCT8 | 5.88e-07 | 451 | 206 | 14 | 36168627 | |
| Interaction | SIRT7 interactions | AARS1 USP9X PSMC3 CHD1 ACTN4 BIRC6 GFPT1 NUP205 GMPS MDN1 UBTF CLTC USP7 UTP20 DYNC1H1 CUL4A IPO5 POLR1A IPO7 UBR4 CHD8 FRYL MSH6 USP5 LRPPRC UBE2O CSE1L GTF3C1 MACF1 TNKS1BP1 EIF4G3 | 2.78e-11 | 744 | 206 | 31 | int:SIRT7 |
| Interaction | AGR2 interactions | ZNF131 EPRS1 AARS1 CLTCL1 PPP2R2D ACOT7 PSMC3 ACTN4 OLA1 GFPT1 RYR1 SAFB MDN1 STXBP3 CLTC USP7 AK2 DYNC1H1 IPO5 UBR4 CHD8 AP3B1 DNAH1 MSH6 USP5 LRPPRC LLGL2 CSE1L GOLPH3L CCT8 MACF1 EIF3A NUTF2 | 4.41e-10 | 934 | 206 | 33 | int:AGR2 |
| Interaction | KCTD13 interactions | EPRS1 SLK ATP6V0A1 MAP1A MARK3 USP9X TTC21A ACOT7 PSMC3 ACTN4 OLA1 JMY DIP2A JUP PHLDB1 CLCN6 CLTC NGEF USP7 LSM4 ARHGAP21 DYNC1H1 MOB4 IPO5 KALRN RAPGEF4 AP3B1 USP5 LRPPRC PPP2R2C UBE2O CSE1L APPL2 PAFAH1B2 EIF4G2 KNDC1 CCT8 MACF1 TNKS1BP1 EIF3A EIF4G3 | 6.58e-10 | 1394 | 206 | 41 | int:KCTD13 |
| Interaction | KCNA3 interactions | EPRS1 DLG5 MARK3 USP9X UNC45A ARFIP1 GFPT1 RYR1 GMPS KMT2C JUP UBTF DNAH5 FAM135A ARHGAP21 DYNC1H1 IPO5 IPO7 COBLL1 ATG2B RNF213 AP3B1 LRPPRC CSE1L EIF4G2 CCT8 MACF1 CARD11 TNKS1BP1 EIF4G3 PARD3 | 1.34e-09 | 871 | 206 | 31 | int:KCNA3 |
| Interaction | CIT interactions | AARS1 CLTCL1 CYP11B1 PSMC3 CHD1 ACTN4 ADGRV1 BIRC6 GFPT1 MAP3K4 NUP205 ACSL4 JUP SAFB UBTF CLTC SCO1 UTP20 LSM4 ACAA2 DYNC1H1 IPO5 POLR1A IPO7 KALRN TNPO2 UBR4 RNF213 CHD8 APOB MSH6 LRPPRC CSE1L PPT1 EIF4G2 CCT8 MACF1 TNKS1BP1 EIF3A PARD3 CCDC180 | 2.10e-09 | 1450 | 206 | 41 | int:CIT |
| Interaction | RMC1 interactions | EPRS1 AARS1 USP9X PSMC3 GMPS ACSL4 JUP ACAA2 DYNC1H1 POLR1A MSH6 CSE1L EIF4G2 | 5.74e-09 | 152 | 206 | 13 | int:RMC1 |
| Interaction | MOB3C interactions | EPRS1 USP9X PSMC3 GMPS JUP PTPN14 MDN1 CLTC USP7 DYNC1H1 CUL4A IPO5 UBR4 MSH6 CSE1L GTF3C1 EIF4G2 CCT8 TNKS1BP1 | 7.05e-09 | 364 | 206 | 19 | int:MOB3C |
| Interaction | ITGB3 interactions | AARS1 USP9X BIRC6 MDN1 CLTC USP7 DYNC1H1 IPO5 IPO7 UBR4 CSE1L EIF4G2 EIF3A | 2.22e-08 | 170 | 206 | 13 | int:ITGB3 |
| Interaction | BAP1 interactions | ZNF131 EPRS1 AARS1 SLK GBF1 USP9X ACOT7 PSMC3 ACTN4 UNC45A GMPS KMT2C MDN1 CLTC USP7 AK2 DYNC1H1 IPO5 IPO7 TNPO2 UBR4 SAE1 AP3B1 MSH6 USP5 LRPPRC UBE2O CSE1L GTF3C1 PPT1 ASXL3 CCT8 MACF1 EIF3A NUTF2 EIF4G3 | 5.34e-08 | 1314 | 206 | 36 | int:BAP1 |
| Interaction | EED interactions | EPRS1 AARS1 ATP6V0A1 USP9X ACTN4 UNC45A OLA1 BIRC6 GFPT1 NUP205 GMPS ACSL4 JUP SAFB PTPN14 VILL GLDC CLTC USP7 UTP20 DYNC1H1 CUL4A IPO5 IPO7 UBR4 MSH3 AP3B1 MSH6 USP5 LRPPRC PPP2R5C CSE1L GTF3C1 XIRP2 CCT8 MACF1 EIF3A MAP2K3 | 6.23e-08 | 1445 | 206 | 38 | int:EED |
| Interaction | RICTOR interactions | RGPD4 EPRS1 AARS1 SLK USP9X ACTN4 UNC45A GFPT1 NUP205 ACSL4 JUP STXBP3 CDC16 CLTC BRD1 DYNC1H1 CUL4A IPO7 ATG2B LRPPRC GTF3C1 CCT8 TNKS1BP1 EIF3A IKBKB NCKAP1L | 6.98e-08 | 759 | 206 | 26 | int:RICTOR |
| Interaction | RHOF interactions | MTG1 DLG5 ATP6V0A1 GBF1 TRPM7 MARK3 USP9X ACTN4 NUP205 JUP MDN1 STXBP3 CLTC UTP20 FAM135A ARHGAP21 IPO7 SAE1 MSH3 CSE1L MACF1 ADGRE5 PARD3 MAP2K3 | 1.11e-07 | 673 | 206 | 24 | int:RHOF |
| Interaction | CDC42 interactions | EPRS1 MTG1 DLG5 AARS1 ATP6V0A1 TRPM7 MARK3 USP9X ACOT7 OLA1 LRCH1 MAP3K4 NUP205 ACSL4 JUP PTPN14 MDN1 STXBP3 INTS2 CLTC SCO1 UTP20 FAM135A ARHGAP21 CUL4A IPO5 COBLL1 FRYL MSH3 CSE1L PHPT1 FHOD1 ADGRE5 PARD3 MAP2K3 | 1.96e-07 | 1323 | 206 | 35 | int:CDC42 |
| Interaction | BIRC3 interactions | EPRS1 AARS1 USP9X PSMC3 CHD1 ACTN4 OLA1 GFPT1 NUP205 JUP SAFB MDN1 UBTF CLTC USP7 CC2D2A UTP20 DNAH5 DYNC1H1 IPO5 POLR1A IPO8 IPO7 UBR4 APOB AP3B1 MSH6 LRPPRC CSE1L GTF3C1 EIF4G2 CCT8 EIF3A GALNT5 IKBKB | 2.39e-07 | 1334 | 206 | 35 | int:BIRC3 |
| Interaction | RNF123 interactions | EPRS1 TTC21A SYNC BIRC6 GFPT1 RYR1 NUP205 GMPS TMCO4 KMT2C DIP2A JUP MDN1 CLTC UTP20 SNX31 DYNC1H1 DNAH3 TNPO2 UBR4 DNAH2 RNF213 MSH6 GTF3C1 CCT8 EIF3A | 3.44e-07 | 824 | 206 | 26 | int:RNF123 |
| Interaction | STIP1 interactions | EPRS1 GBF1 USP9X PSMC3 ACTN4 UNC45A OLA1 ARFIP1 NUP205 GMPS PTPN14 MDN1 CLTC USP7 DYNC1H1 IPO5 IPO8 IPO7 UBR4 ADCK2 AP3B1 USP5 LRPPRC UBE2O CSE1L PPT1 EIF4G2 CCT8 EIF3A | 4.47e-07 | 1006 | 206 | 29 | int:STIP1 |
| Interaction | YWHAZ interactions | DAB2IP CCDC125 DLG5 SLK GBF1 PPP2R2D TRPM7 MARK3 PPP1R14A OLA1 LRCH1 MAP3K4 JUP PHLDB1 PTPN14 CLTC CEP126 BRD1 ARHGAP21 DYNC1H1 BNIP5 IPO7 COBLL1 FRYL AP3B1 LRPPRC PPP2R5C PPT1 ASXL3 FHOD1 MACF1 EIF3A PARD3 MAP2K3 | 5.48e-07 | 1319 | 206 | 34 | int:YWHAZ |
| Interaction | RHOJ interactions | DAB2IP MTG1 DLG5 ATP6V0A1 TRPM7 MARK3 USP9X NUP205 DIP2A JUP PTPN14 MDN1 STXBP3 CLTC UTP20 FAM135A ARHGAP21 CSE1L FHOD1 MACF1 ADGRE5 PARD3 | 6.02e-07 | 633 | 206 | 22 | int:RHOJ |
| Interaction | ANKRD55 interactions | AARS1 USP9X PSMC3 NUP205 MDN1 CLTC USP7 DYNC1H1 IPO5 LRPPRC CSE1L CCT8 EIF3A | 6.78e-07 | 228 | 206 | 13 | int:ANKRD55 |
| Interaction | SUMO2 interactions | EPRS1 AARS1 USP9X PSMC3 SAFB MDN1 CLTC USP7 DYNC1H1 IPO5 KALRN UBR4 SAE1 RNF213 CHD8 MSH3 MSH6 USP5 CSE1L GTF3C1 EIF4G2 | 7.73e-07 | 591 | 206 | 21 | int:SUMO2 |
| Interaction | FASN interactions | EPRS1 GBF1 TRPM7 MARK3 USP9X PSMC3 CHD1 OLA1 BIRC6 GFPT1 KMT2C JUP SAFB INTS2 GLDC UBTF CDC16 GGPS1 DYNC1H1 IPO5 UBR4 CHD8 PPP2R5C LLGL2 PPT1 ASXL3 LRRC20 PAFAH1B2 CCT8 | 1.34e-06 | 1062 | 206 | 29 | int:FASN |
| Interaction | PPP2R1A interactions | CLTCL1 PPP2R2D MARK3 PSMC3 GFPT1 PTPN14 CLCN6 INTS2 CLTC USP7 DYNC1H1 MOB4 CUL4A IPO5 LRPPRC PPP2R2B PPP2R2C PPP2R5C PPT1 ASXL3 CARD11 MAP2K3 | 1.36e-06 | 665 | 206 | 22 | int:PPP2R1A |
| Interaction | RAC1 interactions | DAB2IP DLG5 AARS1 GBF1 TRPM7 MARK3 USP9X MAP3K4 NUP205 JUP PTPN14 MDN1 STXBP3 CLTC UTP20 SNX31 ARHGAP21 IPO8 IPO7 KALRN LRPPRC PPP2R2B LLGL2 CSE1L FHOD1 MACF1 ADGRE5 DSG4 PARD3 | 1.36e-06 | 1063 | 206 | 29 | int:RAC1 |
| Interaction | RHOV interactions | DLG5 TRPM7 MARK3 USP9X NUP205 JUP MDN1 CLTC UTP20 IPO5 CSE1L ADGRE5 PARD3 | 1.39e-06 | 243 | 206 | 13 | int:RHOV |
| Interaction | EFTUD2 interactions | EPRS1 SLK USP9X PSMC3 CHD1 UNC45A OLA1 BIRC6 GFPT1 GMPS GLDC CLTC USP7 SCO1 AK2 LSM4 DYNC1H1 CUL4A IPO5 IPO7 UBR4 AP3B1 DNAJC2 HINFP MSH6 USP5 LRPPRC UBE2O CSE1L FHOD1 EIF4G2 CCT8 MACF1 TNKS1BP1 EIF3A | 1.64e-06 | 1449 | 206 | 35 | int:EFTUD2 |
| Interaction | RHOB interactions | DAB2IP DLG5 SPAG1 SLK MAP1A TRPM7 MARK3 USP9X ARFIP1 LRP8 NUP205 ACSL4 DIP2A JUP PTPN14 MDN1 STXBP3 CLTC UTP20 FAM135A ARHGAP21 CSE1L MACF1 ADGRE5 PARD3 | 1.70e-06 | 840 | 206 | 25 | int:RHOB |
| Interaction | PPP2R5E interactions | 2.26e-06 | 112 | 206 | 9 | int:PPP2R5E | |
| Interaction | KIF23 interactions | EPRS1 DLG5 PSMC3 CHD1 BIRC6 GFPT1 MAP3K4 ACSL4 JUP SAFB UBTF CLTC USP7 ARHGAP21 DYNC1H1 CUL4A IPO5 IPO7 TNPO2 COBLL1 FRYL MSH6 USP5 LRPPRC UBE2O EIF4G2 MACF1 EIF4G3 | 2.31e-06 | 1031 | 206 | 28 | int:KIF23 |
| Interaction | NAA40 interactions | ZNF131 EPRS1 AARS1 SLK MAP1A ACOT7 CHD1 UNC45A ARFIP1 GFPT1 GMPS JUP SAFB UBTF USP7 AK2 ARHGAP21 ATG2B MSH6 UBE2O FHOD1 EIF4G2 CCT8 MACF1 TNKS1BP1 EIF3A EIF4G3 | 2.63e-06 | 978 | 206 | 27 | int:NAA40 |
| Interaction | ATXN1 interactions | USP9X ACOT7 PSMC3 GFPT1 GMPS ACSL4 DIP2A CDC16 USP7 SCO1 BRD1 GGPS1 DYNC1H1 IPO5 IPO8 IPO7 MAGEB18 UBR4 RAPGEF4 CITED1 AP3B1 DNAJC2 LRPPRC CSE1L PHPT1 CCT8 EIF3A EIF4G3 | 2.68e-06 | 1039 | 206 | 28 | int:ATXN1 |
| Interaction | EGLN3 interactions | GBF1 USP9X PSMC3 CHD1 UNC45A LRCH1 BIRC6 GFPT1 NUP205 GMPS PHLDB1 STXBP3 USP7 FAM135A ARHGAP21 DYNC1H1 IPO5 IPO8 UBR4 ATG2B SAE1 CHD8 MSH6 LRPPRC CSE1L GTF3C1 PPT1 CCT8 TJAP1 TNKS1BP1 IKBKB PARD3 | 3.09e-06 | 1296 | 206 | 32 | int:EGLN3 |
| Interaction | CCDC8 interactions | EPRS1 USP9X ACTN4 NUP205 JUP PHLDB1 MDN1 CLTC UTP20 DYNC1H1 TDRKH POLR1A IPO7 APOB LRPPRC UBE2O CSE1L GTF3C1 CCT8 MACF1 EIF3A | 4.01e-06 | 656 | 206 | 21 | int:CCDC8 |
| Interaction | PPP6C interactions | EPRS1 OLA1 BIRC6 GMPS USP7 DYNC1H1 IPO7 DNAJC2 LRPPRC UBE2O CSE1L CCT8 | 4.21e-06 | 228 | 206 | 12 | int:PPP6C |
| Interaction | SNCA interactions | USP9X PSMC3 OLA1 GFPT1 GMPS JUP STXBP3 CLTC USP7 LSM4 ARHGAP21 DYNC1H1 IPO5 IPO7 UBR4 AP3B1 MSH6 PPP2R5C APPL2 MACF1 TNKS1BP1 EIF4G3 | 4.50e-06 | 716 | 206 | 22 | int:SNCA |
| Interaction | EPHA2 interactions | DAB2IP DLG5 ATP6V0A1 MARK3 ARFIP1 LRCH1 LRP8 JUP PHLDB1 PTPN14 STXBP3 CLTC FAM135A ARHGAP21 SLC25A41 LRPPRC PPP2R2B LLGL2 APPL2 MACF1 PARD3 MAP2K3 | 4.81e-06 | 719 | 206 | 22 | int:EPHA2 |
| Interaction | RHOA interactions | MTG1 DLG5 SLK ATP6V0A1 TRPM7 MARK3 USP9X ARFIP1 NUP205 ACSL4 JUP PTPN14 MDN1 STXBP3 CLTC NGEF SCO1 UTP20 FAM135A ELMOD1 ARHGAP21 MOB4 FRYL CSE1L PAFAH1B2 MACF1 ADGRE5 NUTF2 IKBKB PARD3 | 5.04e-06 | 1199 | 206 | 30 | int:RHOA |
| Interaction | RHOH interactions | DAB2IP DLG5 ATP6V0A1 TRPM7 MARK3 USP9X NUP205 JUP MDN1 STXBP3 CLTC USP7 FAM135A SAE1 CSE1L APPL2 ADGRE5 PARD3 | 5.72e-06 | 512 | 206 | 18 | int:RHOH |
| Interaction | SLX4 interactions | CHD1 ACTN4 GMPS JUP SAFB MDN1 UBTF CLTC DYNC1H1 IPO8 IPO7 CHD8 MSH3 AP3B1 MSH6 USP5 PPP2R2C CSE1L CCT8 | 7.02e-06 | 572 | 206 | 19 | int:SLX4 |
| Interaction | ATG16L1 interactions | DLG5 MAP1A PSMC3 ACTN4 LRP8 DIP2A JUP PHLDB1 SAFB PTPN14 UBTF CLTC FAM135A FHIP1A MOB4 IPO5 POLR1A IPO8 IPO7 TNPO2 COBLL1 ATG2B AAGAB DNAJC2 USP5 APPL2 EIF4G2 CCT8 EIF3A | 7.63e-06 | 1161 | 206 | 29 | int:ATG16L1 |
| Interaction | TES interactions | EPRS1 USP9X ACTN4 UNC45A CLTC ACAA2 BRD1 DYNC1H1 CUL4A IPO7 UBR4 MACF1 TNKS1BP1 MAP2K3 | 8.70e-06 | 332 | 206 | 14 | int:TES |
| Interaction | VASP interactions | MAP1A ACTN4 JMY PTPN14 FAM135A ARHGAP21 NSMAF COBLL1 UBR4 XIRP2 FHOD1 TNKS1BP1 PARD3 | 1.11e-05 | 294 | 206 | 13 | int:VASP |
| Interaction | BRCA1 interactions | EPRS1 AARS1 GBF1 ZBTB48 USP9X ACOT7 PSMC3 OLA1 GMPS ACSL4 JUP MDN1 UBTF CDC16 CLTC USP7 BRD1 ARHGAP21 DYNC1H1 IPO5 POLR1A IPO7 UBR4 MSH3 MSH6 PPP2R5C CSE1L CCT8 EIF3A IKBKB | 1.12e-05 | 1249 | 206 | 30 | int:BRCA1 |
| Interaction | RND2 interactions | DLG5 ATP6V0A1 TRPM7 MARK3 USP9X NUP205 JUP MDN1 CLTC UTP20 FAM135A IPO7 CSE1L FHOD1 ADGRE5 PARD3 | 1.27e-05 | 440 | 206 | 16 | int:RND2 |
| Interaction | CDH1 interactions | DAB2IP DLG5 SPAG1 SLK MARK3 USP9X ACTN4 UNC45A OLA1 ARFIP1 NDRG2 JUP PTPN14 ARHGAP21 COBLL1 LRPPRC CSE1L EIF4G2 CCT8 MACF1 TNKS1BP1 PARD3 | 1.35e-05 | 768 | 206 | 22 | int:CDH1 |
| Interaction | MCC interactions | DAB2IP EPRS1 ZBTB48 SYNC DIP2A CLTC BRD1 MOB4 UBR4 EIF3A CCDC180 | 1.39e-05 | 215 | 206 | 11 | int:MCC |
| Interaction | DIRAS3 interactions | DLG5 TRPM7 MARK3 PSMC3 JUP FAM135A ARHGAP21 IPO5 IPO8 IPO7 MACF1 PARD3 | 1.71e-05 | 262 | 206 | 12 | int:DIRAS3 |
| Interaction | HRAS interactions | DAB2IP SPAG1 GBF1 TRPM7 MARK3 TTC21A NDRG3 ACSL4 PHLDB1 STXBP3 RIN2 FAM135A ARHGAP21 CUL4A SLC25A41 APOB MSH6 LLGL2 KNDC1 PARD3 SOS2 | 1.82e-05 | 725 | 206 | 21 | int:HRAS |
| Interaction | TNIP1 interactions | EPRS1 DLG5 AARS1 MARK3 ACTN4 SYNC UNC45A GFPT1 JUP SAFB UBTF CLTC USP7 UTP20 DYNC1H1 CUL4A IPO5 POLR1A IPO7 MAGEB18 APOB LRPPRC LLGL2 CSE1L CCT8 CARD11 EIF3A IKBKB MAP2K3 | 1.85e-05 | 1217 | 206 | 29 | int:TNIP1 |
| Interaction | GRK5 interactions | 1.86e-05 | 182 | 206 | 10 | int:GRK5 | |
| Interaction | CDKN3 interactions | 2.03e-05 | 55 | 206 | 6 | int:CDKN3 | |
| Interaction | PPP2CB interactions | ZNF444 PPP2R2D MARK3 PSMC3 INTS2 MOB4 CUL4A PPP2R2B PPP2R2C PPP2R5C CCT8 MAP2K3 | 2.07e-05 | 267 | 206 | 12 | int:PPP2CB |
| Interaction | UNK interactions | USP9X BIRC6 GFPT1 SAFB CLTC GGPS1 DYNC1H1 CUL4A IPO7 MSH6 CSE1L EIF4G2 CCT8 TNKS1BP1 EIF3A | 2.10e-05 | 408 | 206 | 15 | int:UNK |
| Interaction | WDR5 interactions | EPRS1 AARS1 GBF1 ZBTB48 PSMC3 UNC45A OLA1 GFPT1 NUP205 ACSL4 KMT2C JUP CLTC USP7 LSM4 DYNC1H1 CUL4A IPO5 UBR4 CHD8 LRPPRC UBE2O CSE1L ASXL3 CCT8 MACF1 EIF3A | 2.24e-05 | 1101 | 206 | 27 | int:WDR5 |
| Interaction | RIT1 interactions | EPRS1 DLG5 AARS1 TRPM7 USP9X BIRC6 GFPT1 NUP205 GMPS MDN1 CDC16 CLTC USP7 SCO1 UTP20 LSM4 DNA2 GGPS1 MOB4 POLR1A IPO7 UBR4 SAE1 NBPF20 HINFP LRPPRC CSE1L EIF3A NUTF2 | 2.25e-05 | 1230 | 206 | 29 | int:RIT1 |
| Interaction | KPNA2 interactions | ZNF131 GBF1 ACTN4 NGEF ANKIB1 BRD1 POLR1A IPO7 SAE1 CHD8 MSH6 LRPPRC UBE2O CSE1L ASXL3 IKBKB SOS2 | 2.59e-05 | 519 | 206 | 17 | int:KPNA2 |
| Interaction | CD274 interactions | EPRS1 USP9X INTS2 USP7 UTP20 CUL4A IPO5 IPO8 IPO7 TNPO2 AP3B1 USP5 LRPPRC CSE1L | 2.82e-05 | 369 | 206 | 14 | int:CD274 |
| Interaction | NRP1 interactions | DLG5 USP9X ACTN4 ACSL4 SAFB SCO1 IPO5 POLR1A IPO7 TNPO2 UBR4 SAE1 TJAP1 | 3.08e-05 | 324 | 206 | 13 | int:NRP1 |
| Interaction | CRY2 interactions | EPRS1 PPP2R2D USP9X PSMC3 USP7 DYNC1H1 NPAS2 LRPPRC CSE1L CCT8 | 3.22e-05 | 194 | 206 | 10 | int:CRY2 |
| Interaction | YWHAE interactions | DAB2IP CCDC125 DLG5 GBF1 TRPM7 MARK3 ACTN4 LRCH1 JUP PHLDB1 PTPN14 STXBP3 CLTC BRD1 ARHGAP21 DYNC1H1 BNIP5 IPO8 COBLL1 SAE1 FRYL UBE2O PPP2R5C APPL2 PPT1 PAFAH1B2 MACF1 EIF3A PARD3 | 3.30e-05 | 1256 | 206 | 29 | int:YWHAE |
| Interaction | PPME1 interactions | 3.34e-05 | 156 | 206 | 9 | int:PPME1 | |
| Interaction | PIP4K2C interactions | 3.88e-05 | 159 | 206 | 9 | int:PIP4K2C | |
| Interaction | TRIM28 interactions | SLK MAP1A ACOT7 PSMC3 BIRC6 GFPT1 MAP3K4 NUP205 JUP SAFB CLTC ZNF483 UTP20 ACAA2 DNAH5 DYNC1H1 CUL4A IPO5 POLR1A IPO8 IPO7 UBR4 SAE1 MSH3 AP3B1 MSH6 PPP2R2B UBE2O GTF3C1 PPT1 CCT8 EIF4G3 | 4.12e-05 | 1474 | 206 | 32 | int:TRIM28 |
| Interaction | WDR76 interactions | MDN1 USP7 ACAA2 CUL4A POLR1A TNPO2 CHD8 MSH3 AP3B1 MSH6 LRPPRC CSE1L GTF3C1 CCT8 | 4.23e-05 | 383 | 206 | 14 | int:WDR76 |
| Interaction | LRRK2 interactions | EPRS1 AARS1 OLA1 MDN1 CLTC USP7 AK2 DYNC1H1 RAPGEF4 SAE1 CSE1L PHPT1 XIRP2 PAFAH1B2 CCT8 MAP2K3 | 5.40e-05 | 496 | 206 | 16 | int:LRRK2 |
| Interaction | YAP1 interactions | EPRS1 SLK GBF1 CLTCL1 USP9X PSMC3 CHD1 UNC45A ARFIP1 KMT2C JUP PTPN14 CLTC USP7 DYNC1H1 IPO5 IPO7 CHD8 PKNOX2 MSH6 UBE2O GTF3C1 CCT8 TNKS1BP1 EIF3A PARD3 | 5.53e-05 | 1095 | 206 | 26 | int:YAP1 |
| Interaction | CUL7 interactions | EPRS1 MAP1A CHD1 ACTN4 OLA1 GFPT1 NUP205 JUP SAFB MDN1 UBTF CLTC BRD1 DYNC1H1 IPO5 APOB MSH3 MSH6 USP5 LRPPRC CCT8 MACF1 | 5.71e-05 | 845 | 206 | 22 | int:CUL7 |
| Interaction | HSF1 interactions | EPRS1 AARS1 PSMC3 ACTN4 OLA1 NUP205 GMPS JUP CDC16 CLTC USP7 SCO1 IPO5 IPO8 IPO7 USP5 LRPPRC CSE1L | 5.72e-05 | 609 | 206 | 18 | int:HSF1 |
| Interaction | OPALIN interactions | NUP205 DIP2A MDN1 INTS2 UTP20 IPO8 TNPO2 RNF213 CSE1L ADGRE5 | 6.05e-05 | 209 | 206 | 10 | int:OPALIN |
| Interaction | AKAP1 interactions | USP9X UNC45A BIRC6 NUP205 ACSL4 MDN1 CDC16 USP7 SCO1 UTP20 DYNC1H1 IPO5 TDRKH UBR4 ATG2B LRPPRC | 6.37e-05 | 503 | 206 | 16 | int:AKAP1 |
| Interaction | PPP2R2A interactions | PPP2R2D MARK3 PSMC3 PTPN14 CACNA1S LRPPRC PPP2R2B PPP2R2C PPP2R5C EIF4G2 CCT8 EIF3A | 6.63e-05 | 301 | 206 | 12 | int:PPP2R2A |
| Interaction | DSCAM interactions | 6.83e-05 | 171 | 206 | 9 | int:DSCAM | |
| Interaction | TRIM33 interactions | SLK USP9X ACTN4 GMPS JUP CDC16 CLTC USP7 BRD1 IPO5 IPO7 MSH6 LRPPRC CSE1L EIF3A | 6.93e-05 | 453 | 206 | 15 | int:TRIM33 |
| Interaction | RAC3 interactions | DAB2IP DLG5 TRPM7 MARK3 ARFIP1 DIP2A JUP STXBP3 UBTF CLTC UTP20 FAM135A ARHGAP21 FRYL FHOD1 MACF1 ADGRE5 PARD3 | 7.04e-05 | 619 | 206 | 18 | int:RAC3 |
| Interaction | YWHAG interactions | DAB2IP DLG5 AARS1 SLK GBF1 TRPM7 MARK3 ACTN4 JUP PHLDB1 PTPN14 MDN1 CLTC ACAA2 BRD1 ARHGAP21 DYNC1H1 BICC1 CUL4A BNIP5 COBLL1 FRYL CSE1L PPT1 PAFAH1B2 MACF1 EIF4G3 PARD3 | 7.51e-05 | 1248 | 206 | 28 | int:YWHAG |
| Interaction | NSMAF interactions | 8.35e-05 | 44 | 206 | 5 | int:NSMAF | |
| Interaction | GSK3B interactions | DLG5 AARS1 MAP1A ACTN4 GFPT1 MAP3K4 NUP205 GMPS CLTC USP7 AK2 ARHGAP21 CUL4A IPO5 IPO7 ATG2B UBE2O CSE1L CCT8 MACF1 TNKS1BP1 EIF3A | 8.46e-05 | 868 | 206 | 22 | int:GSK3B |
| Interaction | LCK interactions | DLG5 MARK3 UNC45A DIP2A JUP SAFB PTPN14 USP7 ARHGAP21 KALRN COBLL1 CCT8 MACF1 TNKS1BP1 PARD3 | 8.84e-05 | 463 | 206 | 15 | int:LCK |
| Interaction | PRKCZ interactions | PPP1R14A ACTN4 OLA1 PTPN14 STXBP3 CLTC IPO5 MSH6 LRPPRC UBE2O LLGL2 CSE1L IKBKB PARD3 | 9.24e-05 | 412 | 206 | 14 | int:PRKCZ |
| Interaction | SFN interactions | CCDC125 AARS1 SLK GBF1 MAP1A TRPM7 MARK3 PHLDB1 PTPN14 CLTC USP7 ARHGAP21 IPO5 COBLL1 FRYL PPP2R2B MACF1 PARD3 MAP2K3 | 9.42e-05 | 692 | 206 | 19 | int:SFN |
| Interaction | TOP3B interactions | DAB2IP EPRS1 GBF1 CLTCL1 ACTN4 UNC45A BIRC6 RYR1 KMT2C DIP2A PHLDB1 SAFB MDN1 ZNF296 USP7 LSM4 DNA2 ARHGAP21 DYNC1H1 IPO5 TDRKH DIRAS1 KALRN UBR4 CHD8 APOB FRYL MSH3 LLGL2 DIP2C TNKS1BP1 | 9.42e-05 | 1470 | 206 | 31 | int:TOP3B |
| Interaction | EP300 interactions | ZNF444 SLK CLTCL1 ZBTB48 USP9X SYNC OLA1 BIRC6 JMY GFPT1 GMPS JUP SAFB UBTF CDC16 CLTC USP7 DNA2 NPAS2 CUL4A IPO5 IPO7 CITED1 AP3B1 MSH6 USP5 PPP2R5C CSE1L GTF3C1 IL1A | 9.44e-05 | 1401 | 206 | 30 | int:EP300 |
| Interaction | SPDL1 interactions | EPRS1 CLTCL1 USP9X SYNC CLTC CEP126 IPO5 MSH3 MSH6 CSE1L EIF4G2 EIF3A | 1.02e-04 | 315 | 206 | 12 | int:SPDL1 |
| Interaction | MINDY4 interactions | 1.02e-04 | 73 | 206 | 6 | int:MINDY4 | |
| Interaction | LMBR1L interactions | EPRS1 AARS1 ATP6V0A1 USP9X PSMC3 UNC45A GFPT1 NUP205 STXBP3 CLTC UTP20 DYNC1H1 POLR1A IPO7 UBR4 DNAH2 AP3B1 USP5 LRPPRC UBE2O CSE1L EIF4G2 EIF4G3 | 1.08e-04 | 946 | 206 | 23 | int:LMBR1L |
| Interaction | LINC01554 interactions | 1.08e-04 | 142 | 206 | 8 | int:LINC01554 | |
| Interaction | GJA1 interactions | DLG5 AARS1 GBF1 TRPM7 MARK3 USP9X JUP PTPN14 CLTC USP7 FAM135A ARHGAP21 KALRN APOB TJAP1 MACF1 PARD3 | 1.09e-04 | 583 | 206 | 17 | int:GJA1 |
| Interaction | IMPDH2 interactions | DLG5 SLK GBF1 JMY GMPS ACAA2 DYNC1H1 IPO5 UBR4 ATG2B UBE2O LLGL2 ASXL3 CCT8 | 1.13e-04 | 420 | 206 | 14 | int:IMPDH2 |
| Interaction | GOLGA1 interactions | 1.15e-04 | 183 | 206 | 9 | int:GOLGA1 | |
| Interaction | MCM2 interactions | RGPD4 PPP2R2D USP9X ACTN4 GFPT1 GMPS JUP SERPINB8 CLTC DYNC1H1 MOB4 CUL4A IPO7 UBR4 ATG2B RNF213 DNAH1 LRPPRC PPP2R2B UBE2O CSE1L EIF4G2 CCT8 MACF1 TNKS1BP1 | 1.18e-04 | 1081 | 206 | 25 | int:MCM2 |
| Interaction | PPP5C interactions | MAP1A BIRC6 GLDC CDC16 BRD1 ATG2B UBE2O CSE1L PAFAH1B2 KNDC1 EIF4G3 | 1.18e-04 | 272 | 206 | 11 | int:PPP5C |
| Interaction | RUFY1 interactions | EPRS1 USP9X PSMC3 SYNC NUP205 CLTC USP7 DYNC1H1 IPO7 RNF213 MSH6 LRPPRC UBE2O CSE1L CCT8 | 1.20e-04 | 476 | 206 | 15 | int:RUFY1 |
| Interaction | LIMA1 interactions | GBF1 CLTCL1 PSMC3 ACTN4 JUP PTPN14 GLDC CLTC USP7 BRD1 ARHGAP21 IPO7 UBE2O EIF4G3 | 1.41e-04 | 429 | 206 | 14 | int:LIMA1 |
| Interaction | PPP2CA interactions | PPP2R2D INTS2 CDC16 USP7 MOB4 CUL4A LRPPRC PPP2R2B PPP2R2C PPP2R5C ASXL3 CCT8 CARD11 IKBKB MAP2K3 | 1.44e-04 | 484 | 206 | 15 | int:PPP2CA |
| Interaction | CAPZA2 interactions | CLTCL1 ACTN4 UNC45A CLTC ARHGAP21 BICC1 IPO7 CRAT LRPPRC UBE2O ASXL3 MACF1 TNKS1BP1 DSG4 | 1.45e-04 | 430 | 206 | 14 | int:CAPZA2 |
| Interaction | FBXO22 interactions | AARS1 USP9X MAP3K4 KMT2C DIP2A PHLDB1 MDN1 UBTF USP7 ARHGAP21 POLR1A RAPGEF4 MEI1 GTF3C1 XIRP2 GALNT5 | 1.45e-04 | 540 | 206 | 16 | int:FBXO22 |
| Interaction | CDC34 interactions | EPRS1 AARS1 NUP205 GMPS MDN1 ACAA2 DYNC1H1 MSH6 USP5 LRPPRC GTF3C1 CCT8 | 1.49e-04 | 328 | 206 | 12 | int:CDC34 |
| Interaction | S1PR1 interactions | 1.54e-04 | 112 | 206 | 7 | int:S1PR1 | |
| Interaction | NBR1 interactions | AARS1 GMPS JUP CLTC DYNC1H1 IPO5 IPO7 UBR4 THEM5 LRPPRC UBE2O MACF1 IKBKB | 1.54e-04 | 380 | 206 | 13 | int:NBR1 |
| Interaction | POLR1G interactions | JADE3 CHD1 NUP205 MDN1 UBTF CLTC USP7 UTP20 IPO5 POLR1A UBR4 CHD8 LRPPRC GTF3C1 IKBKB | 1.61e-04 | 489 | 206 | 15 | int:POLR1G |
| Interaction | ATOH1 interactions | 1.70e-04 | 80 | 206 | 6 | int:ATOH1 | |
| Cytoband | 10q26.3 | 8.34e-05 | 51 | 206 | 4 | 10q26.3 | |
| GeneFamily | Dyneins, axonemal | 1.24e-07 | 17 | 135 | 5 | 536 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 3.81e-06 | 15 | 135 | 4 | 696 | |
| GeneFamily | Armadillo repeat containing|Importins | 8.39e-06 | 18 | 135 | 4 | 596 | |
| GeneFamily | Cytochrome P450 family 11 | 1.65e-04 | 3 | 135 | 2 | 1007 | |
| GeneFamily | MutS homologs|PWWP domain containing | 5.45e-04 | 5 | 135 | 2 | 1026 | |
| GeneFamily | Neuroblastoma breakpoint family | 6.46e-04 | 23 | 135 | 3 | 662 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 9.33e-04 | 26 | 135 | 3 | 904 | |
| GeneFamily | Transient receptor potential cation channels | 1.16e-03 | 28 | 135 | 3 | 249 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.72e-03 | 115 | 135 | 5 | 769 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SLK GALK2 GBF1 MARK3 USP9X CHD1 MAP3K4 GMPS ACSL4 MDN1 STXBP3 CDC16 RIN2 USP7 UTP20 MOB4 NSMAF IPO7 FRYL MSH3 AP3B1 DNAJC2 MSH6 LRPPRC PPP2R5C CSE1L MACF1 EIF3A EIF4G3 PARD3 SOS2 | 1.34e-12 | 856 | 206 | 31 | M4500 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | EPRS1 AARS1 SLK ATP6V0A1 MAP1A USP9X OLA1 GFPT1 KMT2C CLTC ZNF483 DNAH5 FAM135A DYNC1H1 PRUNE2 IPO7 COBLL1 AP3B1 LRPPRC APPL2 GTF3C1 PPT1 DIP2C EIF4G3 | 4.78e-07 | 946 | 206 | 24 | M39169 |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | EPRS1 SLK NUP205 GMPS MDN1 CLTC USP7 IPO5 MSH6 CSE1L MACF1 EIF3A | 7.49e-07 | 250 | 206 | 12 | M11318 |
| Coexpression | GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 4.25e-06 | 199 | 206 | 10 | M8381 | |
| Coexpression | LEE_BMP2_TARGETS_DN | ZNF131 AARS1 PUS3 CHD1 NUP205 GMPS MDN1 INTS2 NGEF UTP20 AK2 DNA2 POLR1A THEM5 DNAJC2 MSH6 LRPPRC CSE1L PAFAH1B2 CCT8 NUTF2 | 1.00e-05 | 904 | 206 | 21 | M2325 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.35e-05 | 180 | 206 | 9 | M8239 | |
| Coexpression | GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP | 2.75e-05 | 197 | 206 | 9 | M8159 | |
| Coexpression | GSE29949_MICROGLIA_VS_DC_BRAIN_UP | 2.98e-05 | 199 | 206 | 9 | M8399 | |
| Coexpression | GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN | 2.98e-05 | 199 | 206 | 9 | M6932 | |
| Coexpression | GSE13306_TREG_RA_VS_TCONV_RA_DN | KMT2C PHLDB1 ACAA2 CACNA1S SLC25A41 COBLL1 ARMC9 PPP2R2B UBE2O | 3.10e-05 | 200 | 206 | 9 | M3227 |
| Coexpression | GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN | 3.10e-05 | 200 | 206 | 9 | M7686 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 3.10e-05 | 200 | 206 | 9 | M9186 | |
| Coexpression | LEE_BMP2_TARGETS_DN | ZNF131 PUS3 CHD1 NUP205 GMPS MDN1 INTS2 NGEF UTP20 AK2 DNA2 POLR1A THEM5 DNAJC2 MSH6 LRPPRC CSE1L PAFAH1B2 CCT8 NUTF2 | 4.33e-05 | 922 | 206 | 20 | MM1068 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | AARS1 SLK MARK3 SYNC GFPT1 ZNF394 STXBP3 CLCN6 PKNOX1 BRD1 GGPS1 NSMAF HINFP GOLPH3L TJAP1 EIF3A IL1A SOS2 | 9.39e-05 | 822 | 206 | 18 | M6782 |
| Coexpression | STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP | 9.45e-05 | 134 | 206 | 7 | MM748 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | EPRS1 AARS1 OLA1 NUP205 MDN1 GLDC UTP20 LSM4 IPO5 IPO7 SAE1 ARMC9 MSH6 LRPPRC CSE1L | 1.08e-04 | 612 | 206 | 15 | M4772 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SLK MARK3 USP9X CHD1 BIRC6 JMY SIRPG ACSL4 KMT2C DIP2A UBTF CDC16 DYNC1H1 NSMAF UBR4 RNF213 FRYL PPP2R2B PPP2R5C PPT1 FHOD1 EIF4G2 MACF1 CARD11 ADGRE5 NCKAP1L | 1.21e-04 | 1492 | 206 | 26 | M40023 |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | SPAG1 GALK2 MAP1A TTC21A CDC16 CC2D2A LSM4 CEP126 DNAH5 BICC1 PRUNE2 DNAH3 DNAH2 ARMC9 MSH3 DNAH1 APPL2 GOLPH3L KNDC1 ADGRE5 CFAP46 | 1.53e-04 | 1093 | 206 | 21 | M41649 |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP | 1.80e-04 | 198 | 206 | 8 | M6522 | |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN | 1.87e-04 | 199 | 206 | 8 | M8314 | |
| Coexpression | GSE11924_TFH_VS_TH1_CD4_TCELL_UP | 1.87e-04 | 199 | 206 | 8 | M3151 | |
| Coexpression | GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN | 1.93e-04 | 200 | 206 | 8 | M4533 | |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_DN | 1.93e-04 | 200 | 206 | 8 | M7058 | |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP | 1.93e-04 | 200 | 206 | 8 | M7776 | |
| Coexpression | GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN | 1.93e-04 | 200 | 206 | 8 | M5758 | |
| Coexpression | GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_DN | 1.93e-04 | 200 | 206 | 8 | M5773 | |
| Coexpression | GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN | 1.93e-04 | 200 | 206 | 8 | M6938 | |
| Coexpression | GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 1.93e-04 | 200 | 206 | 8 | M6993 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | EPRS1 GBF1 TRPM7 BIRC6 MAP3K4 CLTC DNA2 RNF213 FRYL MSH6 MACF1 | 1.20e-09 | 186 | 206 | 11 | 8571956890fc9894d766ba294a28e376b4aba428 |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-08 | 192 | 206 | 10 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | GLDC FAM135A FHIP1A BICC1 NPAS2 PRUNE2 LLGL2 DIP2C PARD3 ENPEP | 2.57e-08 | 194 | 206 | 10 | 7002937e8903e037332a215d00fbc7c7843b33f2 |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.13e-07 | 185 | 206 | 9 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.13e-07 | 185 | 206 | 9 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.04e-07 | 193 | 206 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.32e-07 | 195 | 206 | 9 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.32e-07 | 195 | 206 | 9 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.32e-07 | 195 | 206 | 9 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.32e-07 | 195 | 206 | 9 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.32e-07 | 195 | 206 | 9 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.46e-07 | 196 | 206 | 9 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-07 | 197 | 206 | 9 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.11e-07 | 200 | 206 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.69e-07 | 161 | 206 | 8 | 76c993a4533362db2250c88b3ee3ede55362d54e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.37e-06 | 171 | 206 | 8 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-06 | 176 | 206 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 177 | 206 | 8 | 9c7c6824b9011363851f084a500d665f025b026e | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 177 | 206 | 8 | 2bf639e9e801e5144462ffc957f5739e0dfcd500 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-06 | 180 | 206 | 8 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-06 | 184 | 206 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-06 | 184 | 206 | 8 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-06 | 184 | 206 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-06 | 184 | 206 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.56e-06 | 186 | 206 | 8 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.77e-06 | 188 | 206 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-06 | 189 | 206 | 8 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.88e-06 | 189 | 206 | 8 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.37e-06 | 193 | 206 | 8 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-06 | 193 | 206 | 8 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.50e-06 | 194 | 206 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 3.64e-06 | 195 | 206 | 8 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 3.78e-06 | 196 | 206 | 8 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.78e-06 | 196 | 206 | 8 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 196 | 206 | 8 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.92e-06 | 197 | 206 | 8 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-06 | 197 | 206 | 8 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-06 | 197 | 206 | 8 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.92e-06 | 197 | 206 | 8 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-06 | 197 | 206 | 8 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.92e-06 | 197 | 206 | 8 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.07e-06 | 198 | 206 | 8 | a183afe4c2034323f77abfa080f359d67da35e8f | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 4.07e-06 | 198 | 206 | 8 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.07e-06 | 198 | 206 | 8 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 4.07e-06 | 198 | 206 | 8 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.22e-06 | 199 | 206 | 8 | eb05ccae5187e4701bbbe6d714a6d2808fbcf306 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.38e-06 | 200 | 206 | 8 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.38e-06 | 200 | 206 | 8 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.73e-06 | 151 | 206 | 7 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.73e-06 | 151 | 206 | 7 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.66e-06 | 154 | 206 | 7 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.66e-06 | 154 | 206 | 7 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.66e-06 | 154 | 206 | 7 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.66e-06 | 154 | 206 | 7 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.99e-06 | 155 | 206 | 7 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.99e-06 | 155 | 206 | 7 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.78e-05 | 188 | 206 | 7 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 189 | 206 | 7 | bab0fe55643d3ee750355a32b1ff6634fa5cf88d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 190 | 206 | 7 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.08e-05 | 191 | 206 | 7 | 04faa7d2237e45418611153294eb6f7bb690cbde | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.08e-05 | 191 | 206 | 7 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.08e-05 | 191 | 206 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 3.08e-05 | 191 | 206 | 7 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | Ciliated-cil-3|World / Class top | 3.18e-05 | 192 | 206 | 7 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.18e-05 | 192 | 206 | 7 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.29e-05 | 193 | 206 | 7 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.29e-05 | 193 | 206 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-05 | 193 | 206 | 7 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.29e-05 | 193 | 206 | 7 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 194 | 206 | 7 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.40e-05 | 194 | 206 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.51e-05 | 195 | 206 | 7 | d211a836cf711fdb91b10d512f09d462be937cc5 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-05 | 195 | 206 | 7 | 6bb6349d6ec8da094fe1c7c590021989337aeb0b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.51e-05 | 195 | 206 | 7 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 195 | 206 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 195 | 206 | 7 | 3969b8d5fcec8ef1831531a781f7bbcebab5a4ba | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.51e-05 | 195 | 206 | 7 | a3b468125e48f072255cede7645f6692298ecf54 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-05 | 195 | 206 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 3.51e-05 | 195 | 206 | 7 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 3.63e-05 | 196 | 206 | 7 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.63e-05 | 196 | 206 | 7 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.63e-05 | 196 | 206 | 7 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.63e-05 | 196 | 206 | 7 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.63e-05 | 196 | 206 | 7 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 197 | 206 | 7 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.75e-05 | 197 | 206 | 7 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.75e-05 | 197 | 206 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | PND01-Mesenchymal|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-05 | 197 | 206 | 7 | 292b8cc3dafddf5d323fe4e3d3ea5ac61e6ce027 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.75e-05 | 197 | 206 | 7 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 3.87e-05 | 198 | 206 | 7 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.87e-05 | 198 | 206 | 7 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.87e-05 | 198 | 206 | 7 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.00e-05 | 199 | 206 | 7 | 4820f5bcd7bc34c2ebf6a3422cc8eb383a3b5a4e | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.00e-05 | 199 | 206 | 7 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.00e-05 | 199 | 206 | 7 | 10c8729b779073c3bf808e85958d59147f0be5c5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.00e-05 | 199 | 206 | 7 | 867fd292f3879982422e840e087bfdb3b21a8715 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.00e-05 | 199 | 206 | 7 | 5e9fe852a70546c9d235414a2c26ca3e67ba6eb9 | |
| ToppCell | Control-Lymphoid_T/NK-NK|Control / Disease group, lineage and cell class | 4.00e-05 | 199 | 206 | 7 | 94b2693a8378b9b2c58c6aebb2c6658d75b2e3de | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 4.00e-05 | 199 | 206 | 7 | 6f159c1215439ec22374903124085746fa8da333 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.00e-05 | 199 | 206 | 7 | d2c9fb69e5ef75778a1652da293fcf8cfa7ecfcc | |
| Computational | Neighborhood of RAN | 9.93e-06 | 86 | 132 | 8 | GNF2_RAN | |
| Computational | Neighborhood of PPP1CC | 3.64e-05 | 166 | 132 | 10 | MORF_PPP1CC | |
| Computational | Neighborhood of DEAF1 | 6.65e-05 | 57 | 132 | 6 | MORF_DEAF1 | |
| Computational | Neighborhood of NS | 1.21e-04 | 40 | 132 | 5 | GNF2_NS | |
| Computational | Neighborhood of GMPS | 4.63e-04 | 53 | 132 | 5 | MORF_GMPS | |
| Computational | Neighborhood of MSH6 | 5.29e-04 | 31 | 132 | 4 | GNF2_MSH6 | |
| Disease | Calcium channel blocker use measurement | 1.61e-05 | 213 | 200 | 9 | EFO_0009930 | |
| Disease | Malignant hyperthermia, susceptibility to | 4.57e-05 | 2 | 200 | 2 | cv:C5437603 | |
| Disease | Glucocorticoid-remediable aldosteronism | 4.57e-05 | 2 | 200 | 2 | C1260386 | |
| Disease | Malignant hyperthermia | 4.57e-05 | 2 | 200 | 2 | cv:C5779784 | |
| Disease | Malignant hyperpyrexia due to anesthesia | 4.57e-05 | 2 | 200 | 2 | C0024591 | |
| Disease | adrenal cortical adenoma (is_marker_for) | 4.57e-05 | 2 | 200 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | beta thalassemia (is_marker_for) | 4.86e-05 | 11 | 200 | 3 | DOID:12241 (is_marker_for) | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 6.45e-05 | 12 | 200 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | mitochondrial DNA measurement | TTC21A NUP205 SIRPG SERPINB8 USP7 PKNOX1 ABHD8 BICC1 HINFP UBE2O | 8.77e-05 | 328 | 200 | 10 | EFO_0006312 |
| Disease | Colorectal Carcinoma | TRPM7 PPP1R14A CHD1 ACSL4 KMT2C PDILT PKNOX1 DNAH3 KALRN APOB LIFR MSH6 CSE1L CCNB3 DIP2C | 9.67e-05 | 702 | 200 | 15 | C0009402 |
| Disease | mean reticulocyte volume | MARK3 CYP11B1 CHD1 NUP205 DIP2A SAFB CLCN6 CC2D2A LSM4 ARHGAP21 CUL4A POLR1A DNAH2 GTF3C1 PAFAH1B2 MAP2K3 | 1.20e-04 | 799 | 200 | 16 | EFO_0010701 |
| Disease | malignant hyperthermia (is_implicated_in) | 1.37e-04 | 3 | 200 | 2 | DOID:8545 (is_implicated_in) | |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 1.37e-04 | 3 | 200 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | complement factor H-related protein 3 measurement | 1.62e-04 | 169 | 200 | 7 | EFO_0600056 | |
| Disease | pursuit maintenance gain measurement | 1.98e-04 | 123 | 200 | 6 | EFO_0008433 | |
| Disease | platelet component distribution width | MARK3 LRCH1 JMY SIRPG RIN2 USP7 LSM4 NPAS2 CUL4A PRUNE2 KALRN COBLL1 UBE2O MACF1 ADGRE5 | 2.13e-04 | 755 | 200 | 15 | EFO_0007984 |
| Disease | Endometrial cancer | 2.72e-04 | 4 | 200 | 2 | cv:C0007103 | |
| Disease | ENDOMETRIAL CANCER | 2.72e-04 | 4 | 200 | 2 | 608089 | |
| Disease | Rare disease with malignant hyperthermia | 2.72e-04 | 4 | 200 | 2 | cv:C5681128 | |
| Disease | Endometrial carcinoma | 2.72e-04 | 4 | 200 | 2 | cv:C0476089 | |
| Disease | uric acid measurement | CCDC125 TRPM7 ADGRV1 BIRC6 UBTF LSM4 BICC1 NPAS2 DNAH3 POLR1A COBLL1 DIP2C SOS2 | 2.90e-04 | 610 | 200 | 13 | EFO_0004761 |
| Disease | Prostatic Neoplasms | DAB2IP CYP11B2 CHD1 ACSL4 KMT2C JUP USP7 PON1 MSH3 LIFR APPL2 EIF3A PARD3 | 3.19e-04 | 616 | 200 | 13 | C0033578 |
| Disease | Malignant neoplasm of prostate | DAB2IP CYP11B2 CHD1 ACSL4 KMT2C JUP USP7 PON1 MSH3 LIFR APPL2 EIF3A PARD3 | 3.19e-04 | 616 | 200 | 13 | C0376358 |
| Disease | polypeptide N-acetylgalactosaminyltransferase 1 measurement | 4.51e-04 | 5 | 200 | 2 | EFO_0801899 | |
| Disease | neuronal ceroid lipofuscinosis 3 (implicated_via_orthology) | 4.51e-04 | 5 | 200 | 2 | DOID:0110731 (implicated_via_orthology) | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 4.51e-04 | 5 | 200 | 2 | DOID:446 (is_implicated_in) | |
| Disease | aspartate aminotransferase measurement | CCDC125 DLG5 TRPM7 MARK3 CYP11B1 BIRC6 KLRC3 NPAS2 CACNA1S KALRN COBLL1 DNAH2 RNF213 ARMC9 PKNOX2 SOS2 | 4.72e-04 | 904 | 200 | 16 | EFO_0004736 |
| Disease | Ovarian Serous Adenocarcinoma | 4.92e-04 | 23 | 200 | 3 | C1335177 | |
| Disease | coronary artery disease (is_implicated_in) | 6.08e-04 | 100 | 200 | 5 | DOID:3393 (is_implicated_in) | |
| Disease | Conn Syndrome | 6.74e-04 | 6 | 200 | 2 | C1384514 | |
| Disease | Hyperaldosteronism | 6.74e-04 | 6 | 200 | 2 | C0020428 | |
| Disease | protocadherin alpha-7 measurement | 9.39e-04 | 7 | 200 | 2 | EFO_0801973 | |
| Disease | prostate-specific antigen measurement, disease progression measurement | 9.39e-04 | 7 | 200 | 2 | EFO_0008336, EFO_0020660 | |
| Disease | Diuretic use measurement | 1.07e-03 | 169 | 200 | 6 | EFO_0009928 | |
| Disease | testosterone measurement | MAP1A CYP11B1 CYP11B2 BIRC6 SERPINB8 ZNF394 RIN2 USP7 ARHGAP21 POLR1A COBLL1 DNAH2 SAE1 PKNOX2 MSH6 KNDC1 MACF1 TNKS1BP1 SOS2 | 1.14e-03 | 1275 | 200 | 19 | EFO_0004908 |
| Disease | cardiovascular disease | MARK3 CYP11B2 CLCN6 PDILT BICC1 POLR1A APOB AAGAB ENPEP SOS2 | 1.19e-03 | 457 | 200 | 10 | EFO_0000319 |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.40e-03 | 243 | 200 | 7 | EFO_0004612, EFO_0020944 | |
| Disease | Creutzfeldt Jacob Disease | 1.59e-03 | 9 | 200 | 2 | EFO_0004226 | |
| Disease | protein FAM163B measurement | 1.59e-03 | 9 | 200 | 2 | EFO_0802936 | |
| Disease | melanoma | 1.71e-03 | 126 | 200 | 5 | EFO_0000756 | |
| Disease | Primary ciliary dyskinesia | 1.86e-03 | 36 | 200 | 3 | cv:C0008780 | |
| Disease | body fat percentage | GFPT1 MTMR11 UBTF PDILT POLR1A COBLL1 AAGAB CSE1L MACF1 MAP2K3 | 1.93e-03 | 488 | 200 | 10 | EFO_0007800 |
| Disease | bone mineral content measurement | 1.96e-03 | 130 | 200 | 5 | EFO_0007621 | |
| Disease | interstitial lung disease (is_implicated_in) | 1.98e-03 | 10 | 200 | 2 | DOID:3082 (is_implicated_in) | |
| Disease | androstenedione measurement | 1.98e-03 | 10 | 200 | 2 | EFO_0007972 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 2.01e-03 | 37 | 200 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | essential tremor | 2.39e-03 | 136 | 200 | 5 | EFO_0003108 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 2.42e-03 | 11 | 200 | 2 | EFO_0801461 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 2.42e-03 | 11 | 200 | 2 | EFO_0021862 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.50e-03 | 200 | 200 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 2.76e-03 | 274 | 200 | 7 | EFO_0004530, EFO_0004612 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 2.87e-03 | 276 | 200 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | dementia (is_implicated_in) | 2.89e-03 | 12 | 200 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | Congenital myopathy (disorder) | 2.89e-03 | 12 | 200 | 2 | C0270960 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 2.90e-03 | 42 | 200 | 3 | EFO_0022255 | |
| Disease | colorectal cancer, hormone replacement therapy | 3.06e-03 | 88 | 200 | 4 | EFO_0003961, MONDO_0005575 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.15e-03 | 145 | 200 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Hyperlipoproteinemia Type IIb | 3.39e-03 | 13 | 200 | 2 | C1704417 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 3.54e-03 | 364 | 200 | 8 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | cardiotoxicity, response to anthracycline-based chemotherapy | 3.94e-03 | 14 | 200 | 2 | EFO_0005257, EFO_1001482 | |
| Disease | beta-hydroxyisovalerate measurement | 3.94e-03 | 14 | 200 | 2 | EFO_0800125 | |
| Disease | Primary Ciliary Dyskinesia | 3.99e-03 | 47 | 200 | 3 | C4551720 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 4.49e-03 | 49 | 200 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Replication Error Phenotype | 4.53e-03 | 15 | 200 | 2 | C1721098 | |
| Disease | Microsatellite Instability | 4.53e-03 | 15 | 200 | 2 | C0920269 | |
| Disease | age at menopause | 4.69e-03 | 302 | 200 | 7 | EFO_0004704 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 4.76e-03 | 50 | 200 | 3 | EFO_0022247 | |
| Disease | cholesterol to total lipids in small HDL percentage | 5.03e-03 | 51 | 200 | 3 | EFO_0022240 | |
| Disease | Hyperlipoproteinemia Type IIa | 5.15e-03 | 16 | 200 | 2 | C0745103 | |
| Disease | pulmonary fibrosis (is_implicated_in) | 5.15e-03 | 16 | 200 | 2 | DOID:3770 (is_implicated_in) | |
| Disease | health literacy measurement | 5.60e-03 | 53 | 200 | 3 | EFO_0010104 | |
| Disease | Heschl's gyrus morphology measurement | 5.60e-03 | 53 | 200 | 3 | EFO_0005852 | |
| Disease | triglycerides in HDL measurement | 5.60e-03 | 53 | 200 | 3 | EFO_0022317 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 5.81e-03 | 17 | 200 | 2 | cv:C0270914 | |
| Disease | diabetic retinopathy (is_marker_for) | 5.90e-03 | 54 | 200 | 3 | DOID:8947 (is_marker_for) | |
| Disease | triglycerides in medium HDL measurement | 5.90e-03 | 54 | 200 | 3 | EFO_0022321 | |
| Disease | Hypercholesterolemia, Familial | 6.51e-03 | 18 | 200 | 2 | C0020445 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 6.53e-03 | 56 | 200 | 3 | EFO_0022251 | |
| Disease | pulse pressure measurement | TRPM7 MARK3 CYP11B2 ACTN4 LRCH1 DIP2A JUP CLCN6 CDC16 BRD1 BICC1 NPAS2 COBLL1 RNF213 FRYL MEI1 ENPEP SOS2 | 6.74e-03 | 1392 | 200 | 18 | EFO_0005763 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NKSMEIEVLVDADPV | 301 | O00154 | |
| NNPAMEAEILKEIRE | 641 | O60488 | |
| VDIKPANMEELTEVI | 211 | Q00005 | |
| VDIKPANMEDLTEVI | 211 | Q9Y2T4 | |
| PLEIILEDDLTAQEM | 56 | O95696 | |
| LPEIVEEFEKLMVQQ | 346 | Q7Z695 | |
| KKLVELEVECMEEPN | 2291 | Q9HCK8 | |
| IEDIMELKKINPDVN | 81 | Q8N336 | |
| ELLQDLMEVDIDPLD | 2486 | Q9NR09 | |
| LMEVDIDPLDIDLEK | 2491 | Q9NR09 | |
| VIKLVDELMEAPGDV | 301 | P48960 | |
| EIPEEMEEFTVILLN | 966 | Q8WXG9 | |
| DIPKMLDAEDIVNTA | 236 | O43707 | |
| VILADEIKNPAMEKL | 111 | P53367 | |
| APERAEDKAIMAVEQ | 481 | Q8IYW2 | |
| ILDVIEPSEFVKIME | 311 | Q13362 | |
| VDIKPANMEELTEVI | 221 | Q66LE6 | |
| VKDVELVLPEDSMFE | 1011 | Q9P2G1 | |
| VLDFKVMIDNETLPV | 146 | P43155 | |
| EIAQVGKEMEPLIVD | 191 | Q9P1Z9 | |
| LVFLPEDMDQALVDL | 56 | O95424 | |
| KEEIEVDPQFIAQLM | 361 | Q9H694 | |
| EPQEMDIDEILKRAE | 986 | O14646 | |
| EELQLEEFPMLKTLD | 66 | Q99543 | |
| ENMIDKDVELSVVLP | 51 | Q53SF7 | |
| EEPVIKIMVDDAIVI | 1506 | Q96BY7 | |
| KDIMAELESEDILIP | 431 | Q9C0F0 | |
| KFVPVEEDQRMAEIL | 371 | Q96I13 | |
| LLAMQEEPSIEKEAV | 801 | Q8WWL7 | |
| DPEQKEMLIEVIEKL | 181 | O00203 | |
| AEKPQQELVMEELKE | 501 | Q9Y5X5 | |
| ELQLKDEEMIGPIID | 151 | Q9NTK5 | |
| KILDDEAAQELMPVV | 1321 | Q92621 | |
| ELNVPEEEMVLKVVL | 206 | Q8NAB2 | |
| QFLKEMCIVDEPLEE | 236 | Q99743 | |
| ALDLSMEEEVVIKPV | 146 | Q5VWQ8 | |
| PLIKLDDAVNVDEIM | 346 | P20585 | |
| MDELQDVQLTEIKPL | 1 | Q9UGV2 | |
| QDEDQPVLLKEMPEI | 196 | P01583 | |
| KEVEVQLLPELEEMI | 786 | Q14667 | |
| DEPDVLVMAVKLLIE | 2511 | Q9NU22 | |
| EQLDGILSPELDKMV | 1486 | Q8NEZ4 | |
| QLKEVPTLDRADMEE | 36 | O75610 | |
| ELEIPEAQKDLKEMV | 236 | Q9P2G4 | |
| LPAQDKAIVFEIMEA | 1091 | P78559 | |
| MELALGVDLKEVDPI | 156 | Q96M61 | |
| LEMVKEDEAPLALSD | 196 | Q8N9B5 | |
| MDEPVRAEQAKEIQL | 756 | Q6P1M3 | |
| LPKVEEVVSLMNEDE | 626 | O14920 | |
| ALEMALEQKELDQEP | 121 | Q9UKP3 | |
| DEKRVMVDANEVPIQ | 366 | P50440 | |
| PNKEDIRAVELMLQA | 281 | A4FU01 | |
| IMEADLDKDELIQPQ | 596 | Q7Z3E5 | |
| DEMVVELIEKNLETP | 76 | P54819 | |
| LELRVKVMDINDNAP | 141 | Q86SJ6 | |
| IPSCQKLELEEMDVE | 266 | Q9P2D6 | |
| DENVKQIIPMVTELI | 116 | Q9BT17 | |
| IDDREMPVKVEAAIA | 506 | O95373 | |
| KVSVPEEELDAMLQE | 66 | Q01449 | |
| VQAEKKIEVVMAEPL | 26 | O94915 | |
| MAVEQDVLIAVEPVK | 61 | Q01415 | |
| LKPTEEEAEQLLQLM | 401 | Q9H0H0 | |
| DLQEMLARKEFPVDV | 206 | O60229 | |
| GPLLDVVKEMLVNEA | 1746 | Q8TDM6 | |
| VEGKICVMDLEPQDI | 516 | Q96JB8 | |
| MAVKELETVLADEPG | 346 | P55160 | |
| PEEIGQLKQLMELDV | 181 | Q9Y2L9 | |
| IISMVVGQLKADEDP | 81 | P61970 | |
| IEEQLEPAVEKISIM | 1226 | P42704 | |
| VPEDKLQIIIEVTEM | 41 | O95749 | |
| LLEDVLPVQEDDSLM | 441 | Q07075 | |
| EIVDVPVEKLAAMPA | 131 | Q8TCA0 | |
| IKPEVALLDTQDMEN | 636 | O00410 | |
| EDLMVVPDKISEVVE | 796 | P52701 | |
| PEIDQNKDRMLEILE | 706 | P78344 | |
| LNDEDPVVVTKAAMI | 151 | P14923 | |
| LQKVARDIMEIEGEP | 4061 | Q9UPN3 | |
| LVDAIPALADELVME | 161 | Q5TIA1 | |
| MPDEINIDELLELES | 71 | Q96A00 | |
| VMVKFLNDSIVDPVD | 226 | P50897 | |
| VEDIPVMLVGNKCDE | 111 | O95057 | |
| AVPQLEKLVMEDIFI | 696 | Q9P2D7 | |
| LMADPAKVEDQVQLL | 2451 | Q9P2D7 | |
| SEGNPVDDMELIKVL | 3401 | Q9P2D7 | |
| IIDALEMRDAVEKPQ | 2036 | P04114 | |
| DVLDMEEPINKRLFE | 91 | Q13042 | |
| SEEPAEKEDLLQQML | 696 | P51797 | |
| IEEQAKDAAMGPILE | 76 | Q05DH4 | |
| VIGEMNLKPEEVFLA | 351 | P49915 | |
| EELKKPDQDAIIQMI | 236 | P0C671 | |
| PDQDAIIQMIVELLK | 241 | P0C671 | |
| LLADMIVEEEVPNIS | 991 | Q9P2K1 | |
| DQDSPQEVLKMLIDL | 396 | Q86Z20 | |
| LDDILEKIPETFNMA | 4201 | Q9UFH2 | |
| AVVFVDDLNMPAKEV | 2136 | Q8TD57 | |
| LEELDPDFIMAKQVE | 661 | Q14152 | |
| EPEEVEIMATELLKG | 1821 | Q13698 | |
| MAENLVKASVPEDEI | 1021 | Q9P2H0 | |
| KVACPVIEVINDKDM | 611 | Q7Z7M9 | |
| IVINPEKDKDMVQDL | 351 | Q13619 | |
| MNRAKDLVELDPEVE | 251 | Q9H4A5 | |
| VMLPEDVEKLQQVDS | 91 | P15538 | |
| ADDIVATALAVEPMK | 806 | Q9Y2E4 | |
| MPAVDKLLLEEALQD | 1 | Q8NEU8 | |
| IEVQKDPEALAQLML | 616 | Q8NEU8 | |
| EPELDISDQKRIDIM | 321 | P27448 | |
| IPDEIIDMVKEEVVA | 71 | Q9Y4Z0 | |
| DATMLKIIVGDVDEP | 366 | Q13634 | |
| EPQDMKVAEVLFDAA | 501 | Q14204 | |
| DPDEKVAMLTQILEF | 546 | Q92636 | |
| QLLPKAMIEVEDFVD | 1041 | Q92538 | |
| PAKIAEVMEELKAVE | 1606 | Q76NI1 | |
| VMLPEDVEKLQQVDS | 91 | P19099 | |
| ADDVVATALAVEPMK | 821 | Q14689 | |
| EIAEPLFDLKVGMEQ | 796 | Q9Y613 | |
| IMEKLQGIAEEPEIQ | 501 | Q9BQA5 | |
| CNIEVVKPMDIEESI | 251 | P51530 | |
| ELAADVKQKIPEMID | 4156 | Q9P225 | |
| DVCPEELEKMIQVVD | 171 | O75880 | |
| DEDVKQILKMIEPEV | 1856 | P21817 | |
| QILKMIEPEVFTEEE | 1861 | P21817 | |
| ELEILENPPEEMKLE | 386 | O43432 | |
| DDPELDNLMVKAIQV | 126 | Q96KN3 | |
| PKKEQVLELERENEM | 261 | Q9BXL7 | |
| GPVDENLMEKTVEVL | 161 | Q92613 | |
| ETIELDKPVMAEGNV | 1771 | Q8TE73 | |
| IASMEIPNDDLKIEQ | 621 | P42702 | |
| IPMLKNVVALDVEVA | 446 | Q14114 | |
| ELIMQLLEETPEEKQ | 211 | P68402 | |
| FSLDDMVKLVEVPND | 266 | Q8TEW0 | |
| EDKMKLFPVEVEIID | 111 | Q9Y5H4 | |
| LIEDKEMPVKVEAAL | 506 | O15397 | |
| DKNMTIPEDILGEIA | 156 | P46734 | |
| FMLQEVLEDLEKPDC | 671 | Q9Y6R4 | |
| VIEEEVLAEEKEVPM | 511 | Q8N807 | |
| AEIQEMKEALRPLQA | 366 | Q9H7C4 | |
| IVMDIVDDLLNLPDF | 1251 | O75691 | |
| MVPQFLENLTDEELK | 281 | Q93008 | |
| VVQMPEKVELVIGEE | 1041 | Q7Z3J3 | |
| DDARMIAALKEQLPE | 611 | Q8WZA2 | |
| VILEDVAMLHIKPDQ | 251 | P07814 | |
| QGMEKPEIIDELLNI | 291 | Q9BZE2 | |
| LLALMAQEQKLPEEV | 341 | O95602 | |
| MLDSVLLKEENEQPL | 551 | Q07890 | |
| PIKEIVEMNEIEEGK | 601 | Q9H2G2 | |
| ILEEMKPLESLALEE | 2676 | Q8WUY3 | |
| MSKDNLIVPILEEEV | 201 | Q9Y3A3 | |
| LLMDLNEEDPTVLEL | 86 | P27169 | |
| QVPLEELDVLEEMFL | 146 | Q5TGY1 | |
| LPDLIKEVLSMDDEI | 531 | Q06210 | |
| MAELQEVQITEEKPL | 1 | Q9UN36 | |
| VLMEVEEPEVLQDSL | 831 | Q3BBV2 | |
| VLMEVEEPEVLQDSL | 1381 | Q5TAG4 | |
| VLMEVEEPEVLQDSL | 5131 | P0DPF2 | |
| DPETDNLMVKAIQVL | 111 | P55347 | |
| ILQPEEIKLQEAMFE | 266 | Q8N5V2 | |
| VLFPMDLALEEAVLE | 166 | Q15678 | |
| QLMVPVEVLEVDNKE | 76 | Q8N5S1 | |
| NLNPMVDVKVDTEDI | 101 | Q9UBE0 | |
| IDNEEEMKFLASILP | 156 | Q07444 | |
| MAVADLALIPDVDID | 1 | Q9NRX4 | |
| VAGEEELQMIQPEKL | 26 | Q9P1W8 | |
| PFIKDIMEDAIDNRL | 476 | O00186 | |
| LVEGEMKELPEQLQE | 166 | Q15424 | |
| VKLAAENTEMQIEVP | 381 | Q8N9S9 | |
| VEEELSMVILLPDDN | 221 | P50452 | |
| SIVDPMLDLDIQELA | 236 | Q6PD74 | |
| DPVDEEVLMSLVVEL | 151 | Q99966 | |
| MTADLPNELIELLEK | 996 | Q00610 | |
| MTADLPNELIELLEK | 996 | P53675 | |
| DLPVNIKFIIEGMEE | 186 | Q96KN2 | |
| LLSLEAMIEDPELQV | 141 | Q5SYC1 | |
| LKDMDLVEVNEAFAP | 311 | P42765 | |
| EQEEPLTDAERMKLL | 31 | Q5JTD0 | |
| EVKEIKPVEMDIQAG | 1006 | A4UGR9 | |
| VVLDEVGLAEDSPKM | 2841 | Q63HN8 | |
| LIIEDEKMVVVALQP | 616 | P10074 | |
| EKMVVVALQPPAELE | 621 | P10074 | |
| LIPEDQIDVVLEKAM | 581 | Q8WYP3 | |
| MEVAVPVKQEAEGLA | 1 | Q8N0Y2 | |
| ENKELIPMQQILEEA | 201 | Q53GI3 | |
| KVIVPNMEFRAADEE | 346 | P55060 | |
| QEIPNADKSLEMEIL | 1031 | O75762 | |
| DDIEIEMRVPQEAVK | 51 | Q9Y2W6 | |
| EEVMVDALVSNKPEF | 381 | Q9NZQ8 | |
| AEPIREEENEMIKLT | 66 | P12872 | |
| EEENEMIKLTAPLEI | 71 | P12872 | |
| KDPDMVKDIINEEEV | 366 | P49588 | |
| KNLIPVDSLVVMDVE | 191 | Q8N1Q8 | |
| QELVEAIVLPMNHKE | 196 | P17980 | |
| EAPDKDFMIVALDLL | 631 | O14787 | |
| DPSIIEAKMELEEVT | 721 | Q07617 | |
| VEEILAKMEQPRKEV | 161 | Q9C0C2 | |
| VAIVEEEKMEAVPDV | 871 | Q9C0C9 | |
| IMLKIPEECVAEEEL | 111 | Q5BVD1 | |
| ILPAEGMDIEEVEKL | 251 | O75830 | |
| DEAEVLEFPMVVKNT | 146 | Q9ULI2 | |
| KEMEKLLLPAVDLEQ | 911 | Q86UU1 | |
| DALMSILEPEKALEV | 736 | Q8NDW8 | |
| QIGVVDDEAKAPDLM | 206 | O15195 | |
| PRDMIDLEANFEKIE | 91 | Q93050 | |
| LIEDLTQMLEEKDPV | 126 | Q8TF39 | |
| LDLPEMEILLTKAEN | 21 | Q8IXB3 | |
| MPVEVQTELLEADLD | 551 | P52739 | |
| PEEEQQRVLGEEKML | 366 | P17480 | |
| GDIAVIEEVRMENPK | 576 | Q12789 | |
| TALLKQMEELIEEPG | 4821 | Q5T4S7 | |
| LELSVMPKDEDILQV | 151 | Q5T5U3 | |
| DIEAEVPAVKDMLEA | 481 | P50990 | |
| PLDQVDIDKENEMLV | 976 | Q93009 | |
| PMEVFKEVRILDSNE | 811 | Q96QT4 | |
| QAEEEKMALPELVRA | 511 | P45974 | |
| AKVEQMFQILLDPEE | 151 | Q9H3U1 | |
| EMQDLVIELKPEPDA | 26 | Q8WUU4 | |
| KMEDPVCENEILATL | 106 | P23378 | |
| KLLEVDLDTVPMAEE | 946 | Q6PIF6 |